Covid-19 suspected case

U22_COVID19_SUSPECTED

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — U072 Cause of death: ICD-10 — U072 2 out of 7 registries used, show all original rules.	11042
4. Check minimum number of events None	11042
5. Include endpoints None	11042
6. Filter based on genotype QC (FinnGen only)	10551

Control definitions (FinnGen only)

Control conditions: not U22_COVID19_CONFIRMED

Extra metadata

First used in FinnGen datafreeze: DF6

NAME	U22_COVID19_SUSPECTED
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!U22_COVID19_CONFIRMED
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	U072
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	U072
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Covid-19 suspected case based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	50989	30684	19963
Only index persons	42809	26970	15839
Unadjusted period prevalence (%)
Whole population	0.75	0.88	0.56
Only index persons	0.85	0.99	0.60
Median age at first event (years)
Whole population	33.88	35.56	31.28
Only index persons	38.32	38.63	37.78

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10551	7070	3481
Unadjusted period prevalence (%)	2.21	2.51	1.59
Median age at first event (years)	53.00	50.11	58.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11042: Matched controls
110418

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J11.8

ICD-10 Finland

Influenza with other manifestations, virus not identified

11.3

307.7

348

318

Z36.4

ICD-10 Finland

Antenatal screening for fetal growth retardation using ultrasound and other physical methods

9.4

307.7

527

585

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.5

307.7

1332

4113

U07.2

ICD-10 Finland

COVID-19, virus not identified

14207.6

307.7

11038

17903

J12.8

ICD-10 Finland

Other viral pneumonia

66.8

288.9

158

A77

ICPC

Viral disease other/NOS

3.8

233.0

755

2097

R83

ICPC

Respiratory infection other

1.9

220.5

3904

24266

R4135

NOMESCO Finland

Rehabilitation for hearing problems

8.1

216.8

295

375

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.1

212.0

2686

14809

Z3231

NOMESCO Finland

Registered nurse

2.0

205.2

3120

18325

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.2

179.8

1755

8691

Z50.1

ICD-10 Finland

Other physical therapy

3.3

174.4

703

2242

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.3

157.7

1323

6131

SCB01

NOMESCO Finland

Instructions for self-performed oral hygiene, short

6.5

153.2

254

401

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.7

150.0

4231

29407

SPAT1312

SPAT

General health counselling

1.7

148.8

3841

26042

Z36.8

ICD-10 Finland

Other antenatal screening

4.0

142.9

424

1102

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

5.8

125.7

234

414

XQ845

NOMESCO Finland

Dermatoscopy

5.1

123.4

264

530

SPAT1107

SPAT

Extensive external surface anaesthesia of skin with cream or gel

26.6

119.5

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.3

119.0

954

4312

SPAT1059

SPAT

Spirometry at the office

2.9

118.5

603

2190

HANKE, ,

NOMESCO Finland

19.1

116.2

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

7.7

109.6

154

203

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.3

109.1

418

1287

SPAT1165

SPAT

Peritoneal dialysis

45.3

106.6

Z3229

NOMESCO Finland

Other healthcare associate professional

2.3

100.7

853

3937

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

100.5

3473

24777

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

98.9

2075

13036

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.8

96.3

296

788

R4110

NOMESCO Finland

Physiotherapy

1.6

93.6

2610

17632

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.2

92.4

376

1201

A23

ICPC

Risk factor NOS

2.0

89.2

1142

6149

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

7.1

87.7

132

188

K28

ICPC

Limited function/disability (K)

4.3

87.2

228

539

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

82.6

1998

12970

WYA00

NOMESCO Finland

Screening and health check-up

3.9

82.4

243

628

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

78.6

1953

12746

SPAT1127

SPAT

Enema

7.6

76.1

108

144

WVA20

NOMESCO Finland

Medicine administration

3.2

75.0

312

1009

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

74.3

1972

13064

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

70.7

3184

23664

SPAT1057

SPAT

Peak expiratory flow measurement

3.2

70.2

288

924

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

69.4

2914

21336

Z36.1

ICD-10 Finland

Antenatal screening for raised alphafetoprotein level

7.1

68.4

103

147

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.4

66.2

480

10197

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

65.7

2462

17573

MAC99

NOMESCO Finland

Other augmentation of labor

20.1

65.2

SPAT1062

SPAT

Lung clearance therapy

13.5

63.0

SPAT1172

SPAT

Guidance concerning hydration

3.8

62.8

197

532

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

62.5

2000

13774

SPAT1279

SPAT

Preparation of immediate hospitalisation

5.7

61.9

114

200

R06.0

ICD-10 Finland

Dyspnoea

1.5

61.4

2266

16087

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.4

60.1

222

668

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

59.5

5913

50128

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

59.2

1042

6163

SPAT1324

SPAT

Screening procedure

1.5

58.4

2038

14278

A10BA02

ATC

metformin; oral

1.5

57.7

2113

14954

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

57.4

820

4552

L28

ICPC

Limited function/disability (L)

1.7

57.3

1303

8257

XCW10

NOMESCO Finland

Assessment of vision

4.1

56.3

153

373

R50.9

ICD-10 Finland

Fever, unspecified

1.6

56.3

1429

9307

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.5

55.4

358

1461

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.8

54.7

279

1012

RTGKO, ,

NOMESCO Finland

10.8

53.9

CS2P4

NOMESCO Finland

Optic nerve head imaging

5.1

53.5

112

221

SPAT1138

SPAT

Guidance concerning bowel function

3.5

52.0

183

534

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

3.9

51.1

152

396

A98

ICPC

Health maint/preventive medicine

2.6

50.8

10795

104209

Z46.7

ICD-10 Finland

Fitting and adjustment of orthopaedic device

9.9

50.6

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

50.5

2267

16650

A10AB05

ATC

insulin aspart; parenteral

1.9

49.9

686

3758

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

49.8

1140

7223

A02BC02

ATC

pantoprazole; systemic

1.3

49.0

6299

54811

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

49.0

3785

30492

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

4.6

48.6

114

248

K01.17

ICD-10 Finland

Retained molar with obstruction in the lower jaw

2.2

48.3

424

1977

R02

ICPC

Shortness of breath/dyspnoea

1.6

47.7

1123

7160

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

47.7

1603

11092

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

47.6

937

5705

R4180

NOMESCO Finland

Podiatric therapy

3.9

46.6

139

363

ZB0.1

ICD-10 Finland

Right side

17.3

46.2

J01CF05

ATC

flucloxacillin; systemic

1.9

46.1

615

3336

R03AC02

ATC

salbutamol; inhalant

1.3

45.9

5587

48017

WX402

NOMESCO Finland

General anaesthesia

1.4

44.9

1996

14587

R05

ICPC

Cough

1.4

44.9

2341

17616

J01MA02

ATC

ciprofloxacin; systemic

1.4

44.0

3251

25897

R01AD09

ATC

mometasone; nasal

1.3

43.8

4750

40048

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

43.3

960

6023

XF602

NOMESCO Finland

Bloodpressure monitoring

3.8

43.1

131

347

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

42.6

557

3001

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

42.3

415

2020

SPAT1263

SPAT

Sampling

1.3

42.1

4152

34475

LCA96

NOMESCO Finland

Other intrauterine operation

4.6

41.8

217

A10AE04

ATC

insulin glargine; parenteral

1.7

41.4

761

4541

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.8

41.1

699

4082

SPAT1125

SPAT

Stoma care and guidance

3.8

40.9

126

337

R42

ICD-10 Finland

Dizziness and giddiness

1.4

40.2

1843

13517

A10AE05

ATC

insulin detemir; parenteral

2.0

40.2

482

2522

Z01.7

ICD-10 Finland

Laboratory examination

1.5

40.1

1368

9471

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

40.0

489

2576

XMA22

NOMESCO Finland

General examination of pregnant woman

1.8

39.8

666

3869

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

39.8

1298

8901

Z09.9

ICD-10 Finland

Follow-up examination after unspecified treatment for other conditions

3.4

39.2

139

408

J45

ICD-10 Finland

Asthma

1.6

39.2

993

6431

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

39.1

1129

7536

DMW00

NOMESCO Finland

Intubation of maxillary antrum

7.6

38.6

SPAT1304

SPAT

Counselling and guidance related to ageing

2.0

38.5

403

2009

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.5

38.4

132

380

WX722

NOMESCO Finland

PEEP

2.1

37.4

351

1680

WX199

NOMESCO Finland

Other local analgesia

2.4

37.4

270

1160

ZXA10

NOMESCO Finland

Bilateral

1.5

37.3

1471

10475

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.6

37.2

212

815

R53

ICD-10 Finland

Malaise and fatigue

1.4

36.8

2250

17311

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

5.2

36.5

146

ZXA05

NOMESCO Finland

Left side

1.4

36.4

1828

13602

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

36.0

523

2912

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

35.6

1645

12055

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

35.4

699

4251

MAC96

NOMESCO Finland

Other induction or advancement of labour

2.2

35.4

302

1393

D82

ICPC

Teeth/gum disease

0.7

35.2

2683

33122

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

35.1

979

6480

Z71.8

ICD-10 Finland

Other specified counselling

1.3

34.9

3136

25525

R03BA05

ATC

fluticasone; inhalant

1.4

34.8

1738

12908

Z29.0

ICD-10 Finland

Isolation

8.4

34.7

A10AE06

ATC

insulin degludec; parenteral

2.1

34.3

338

1648

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

5.0

34.0

144

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.7

33.8

697

4285

N17

ICPC

Vertigo/dizziness

1.5

33.7

973

6487

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

33.4

3463

28705

R01AD58

ATC

fluticasone, combinations; nasal

1.3

33.3

2649

21165

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

33.0

374

1918

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

33.0

2057

15838

SCC01

NOMESCO Finland

Fluoride application or other respective small prophylactic procedure

2.0

32.9

352

1770

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

32.7

1856

14070

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

32.5

1180

8250

Z2221

NOMESCO Finland

Medical doctor

1.3

32.5

2533

20162

SPAT1262

SPAT

Handing over of treatment supplies

1.5

32.4

1285

9144

A02BC05

ATC

esomeprazole; systemic

1.3

32.0

3518

29337

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

31.8

1718

12911

J20

ICD-10 Finland

Acute bronchitis

1.5

31.8

919

6126

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.2

31.7

261

1186

D11

ICPC

Diarrhoea

1.5

31.4

1270

9065

UJF32

NOMESCO Finland

Coloscopy

1.4

31.4

1937

14876

H04AA01

ATC

glucagon; nasal, parenteral

2.2

31.0

277

1302

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

30.9

1620

12113

D01

ICPC

Abdominal pain/cramps general

1.5

30.7

1217

8654

T90

ICPC

Diabetes non-insulin dependent

1.4

30.4

1572

11720

R21

ICPC

Throat symptom/complaint

1.3

30.3

2533

20336

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

30.2

740

4746

A10BH05

ATC

linagliptin; oral

2.1

30.1

307

1517

B01AF02

ATC

apixaban; oral

1.6

30.0

705

4478

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.5

29.9

912

6146

EB1AA, ,

SPAT

1.7

29.7

633

3923

R4130

NOMESCO Finland

Speech therapy

2.4

29.6

208

884

N02BE01

ATC

paracetamol; systemic, rectal

1.3

29.2

8985

84573

R51.80

ICD-10 Finland

Headache

1.4

29.1

1588

11941

TPH10

NOMESCO Finland

Sclerotherapy of varicose veins

3.8

29.0

229

R05

ICD-10 Finland

Cough

1.4

28.9

1879

14524

Z96.5

ICD-10 Finland

Presence of tooth-root and mandibular implants

5.5

28.9

100

H25.8

ICD-10 Finland

Other senile cataract

1.7

28.8

567

3443

B01AB10

ATC

tinzaparin; parenteral

1.6

28.7

772

5061

U13

ICPC

Bladder symptom/complaint other

2.2

28.6

247

1146

A04

ICPC

Weakness/tiredness general

1.4

28.4

1355

9956

J01AA02

ATC

doxycycline; systemic

1.3

28.0

7278

66791

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

5.0

27.9

118

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.8

27.6

421

2380

A03

ICPC

Fever

1.3

27.5

1830

14185

N05CF01

ATC

zopiclone; oral

1.3

27.4

2499

20255

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.7

27.3

142

522

R03BA02

ATC

budesonide; inhalant

1.4

27.0

1597

12153

S29

ICPC

Skin symptom/complaint other

1.4

26.9

1607

12250

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

26.9

1582

12031

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

26.7

608

3829

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

26.5

791

5304

A10BK01

ATC

dapagliflozin; oral

1.7

26.5

473

2798

R03BB04

ATC

tiotropium bromide; inhalant

1.6

26.4

625

3976

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

26.4

2457

19956

C08CA01

ATC

amlodipine; oral

1.3

26.2

2459

19984

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

26.2

2379

19255

WZC30

NOMESCO Finland

Teaching

1.4

26.1

1212

8855

XKD00

NOMESCO Finland

Uroflowmetry

1.5

26.0

883

6080

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

3.0

26.0

113

377

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.5

25.9

722

4769

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

25.8

432

2510

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

25.7

822

5591

Z3226

NOMESCO Finland

Physiotherapist

1.4

25.5

1464

11084

A02BC01

ATC

omeprazole; systemic

1.3

25.4

2192

17606

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

25.4

620

3972

A11

ICPC

Chest pain NOS

1.6

25.4

589

3729

O70.0

ICD-10 Finland

First degree perineal laceration during delivery

2.8

25.2

128

465

X23

ICPC

Fear sexually transm dis female

1.5

25.0

710

4710

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

24.7

597

3816

S06.0

ICD-10 Finland

Concussion

1.5

24.5

955

6758

A07AA02

ATC

nystatin; oral

1.7

23.8

409

2393

A10BH01

ATC

sitagliptin; oral

1.6

23.1

581

3747

R96

ICPC

Asthma

1.5

23.1

769

5275

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.0

22.9

247

1247

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

22.9

218

1052

XA410

NOMESCO Finland

BAEP

7.4

22.9

J01FA06

ATC

roxithromycin; oral

1.2

22.8

3441

29503

UKC02

NOMESCO Finland

Cystoscopy

1.4

22.6

966

6947

R31

ICD-10 Finland

Unspecified haematuria

1.6

22.6

611

4009

UDC00

NOMESCO Finland

Ear microscopy

1.6

22.6

609

3993

A10BD07

ATC

metformin and sitagliptin; systemic

1.9

22.3

278

1475

Catheterization and pressure measurement of the left side of the heart

3.0

22.3

319

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

22.3

725

4948

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.7

22.2

120

451

EB1HA, ,

SPAT

2.2

22.1

185

849

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.8

22.1

356

2046

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

2.7

21.9

117

437

N30.0

ICD-10 Finland

Acute cystitis

1.3

21.9

1425

10979

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

21.8

391

2315

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.9

21.8

276

1473

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

21.7

481

3009

SPAT1310

SPAT

Counselling related to known health issue

0.8

21.7

2006

24500

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

21.5

234

1186

SPAT1053

SPAT

Memory test

1.5

21.5

686

4663

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

21.4

326

1842

EB1B, ,

NOMESCO Finland

43.4

21.4

C01CA24

ATC

epinephrine; parenteral

1.5

21.4

618

4114

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

0.5

21.3

184

3723

N06AA12

ATC

doxepin; systemic

1.8

21.3

342

1963

O70.1

ICD-10 Finland

Second degree perineal laceration during delivery

1.8

21.3

306

1700

QBB99

NOMESCO Finland

Other procedure for wound of skin of trunk

5.4

21.1

L17

ICPC

Foot/toe symptom/complaint

1.3

21.1

2391

19816

ZXA00

NOMESCO Finland

Right side

1.3

21.1

1854

14889

N06AB04

ATC

citalopram; systemic

1.3

21.1

1733

13794

XQ800

NOMESCO Finland

Prick test

1.5

21.0

737

5104

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.1

21.0

196

939

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

20.9

344

1988

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

20.9

594

3937

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.9

20.9

280

1521

J05AB11

ATC

valaciclovir; oral

1.4

20.8

1204

9104

R07.3

ICD-10 Finland

Other chest pain

1.5

20.7

759

5304

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

20.6

1127

8449

67009

ICD-8 Finland

Sepsis of childbirth and the puerperium, Unspecified

5.3

20.6

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.2

20.5

246

ZX100

NOMESCO Finland

Oral

2.7

20.4

110

413

R03BA08

ATC

ciclesonide; inhalant

1.5

20.4

733

5103

H02AB07

ATC

prednisone; oral

1.4

20.1

1005

7424

WX110, ,

SPAT

1.5

20.1

562

3715

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

19.9

543

3569

R00.2

ICD-10 Finland

Palpitations

1.5

19.7

690

4779

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

19.7

1376

10702

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.1

19.6

187

904

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

19.5

2186

18068

T78.4

ICD-10 Finland

Allergy, unspecified

1.6

19.3

450

2853

SPAT1167

SPAT

Insertion of urinary catheter

2.1

19.3

171

804

SCA01

NOMESCO Finland

Preventive oral health care, short

0.8

19.2

2231

26606

C03CA01

ATC

furosemide; systemic

1.3

19.2

1574

12510

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

19.2

7090

65965

A10BJ06

ATC

semaglutide; parenteral

1.7

19.1

353

2109

N06AX11

ATC

mirtazapine; oral

1.2

18.9

2968

25443

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.1

18.8

177

851

R29

ICPC

Respiratory symptom/complaint other

1.5

18.8

571

3842

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

18.7

624

4281

RD211, ,

NOMESCO Finland

0.4

18.6

2071

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

2.7

18.5

365

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

0.5

18.5

131

2841

QXA05

NOMESCO Finland

Skin division, unspecified location

4.3

18.5

110

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

18.2

5172

46866

B01AB05

ATC

enoxaparin; parenteral

1.2

18.2

2321

19449

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

18.2

1087

8258

H02AB06

ATC

prednisolone; systemic

1.2

18.0

4036

35784

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

18.0

3381

29484

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

17.9

1071

8135

K30

ICD-10 Finland

Functional dyspepsia

1.4

17.9

932

6927

R11

ICD-10 Finland

Nausea and vomiting

1.4

17.8

721

5132

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

17.8

1143

8776

ZXH06, ,

SPAT

0.4

17.7

2227

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

17.7

775

5592

Z29.8

ICD-10 Finland

Other specified prophylactic measures

1.8

17.7

257

1434

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.3

17.7

138

617

B34.9

ICD-10 Finland

Viral infection, unspecified

1.7

17.6

297

1730

R33

ICD-10 Finland

Retention of urine

1.6

17.6

419

2668

J01MA14

ATC

moxifloxacin; systemic

1.5

17.6

636

4431

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

17.5

603

4161

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

17.5

530

3563

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

17.5

519

3475

R31

ICPC

Respiratory, Medical examin/health eval partial

5.2

17.4

E66

ICD-10 Finland

Obesity

1.5

17.4

489

3237

XQ802

NOMESCO Finland

Epicutan test

1.6

17.4

375

2334

LDA00

NOMESCO Finland

Dilatation of cervix uteri

2.9

17.3

283

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

17.3

2448

20729

A28

ICPC

Limited function/disability NOS

1.4

17.3

886

6568

Z12.4

ICD-10 Finland

Special screening examination for neoplasm of cervix

0.3

17.1

1559

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

17.1

1839

15105

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.1

17.0

155

737

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

3.3

17.0

187

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

17.0

999

7566

W19

ICD-10 Finland

Unspecified fall

1.4

16.9

740

5339

J01CA04

ATC

amoxicillin; systemic

1.2

16.9

8648

82392

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.0

16.9

191

983

W90

ICPC

Uncompl labour/delivery livebirth

0.6

16.9

217

3874

R55

ICD-10 Finland

Syncope and collapse

1.4

16.8

731

5272

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

16.7

1048

8013

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

16.7

351

2171

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

16.6

3912

34763

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

2.8

16.6

284

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

2.5

16.6

106

434

SPAT1368

SPAT

Periodic check-up in occupational healthcare

0.2

16.6

1145

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

16.5

1551

12529

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

16.4

799

5871

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.4

16.4

109

455

WX002

NOMESCO Finland

Sedation and analgesia

1.3

16.3

1358

10800

N05AH04

ATC

quetiapine; oral

1.3

16.3

1655

13495

-44

ICPC

Preventive immunization/medic

0.6

16.2

233

4033

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

16.2

891

6678

Y94.8

ICD-10 Finland

Other leisure activity accident

1.8

16.2

230

1276

N05BA04

ATC

oxazepam; oral

1.2

16.2

2196

18496

ZB0.0

ICD-10 Finland

Left side

15.3

16.1

A10BJ02

ATC

liraglutide; parenteral

1.9

16.1

213

1155

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

16.0

1106

8574

A46

ICD-10 Finland

Erysipelas

1.4

16.0

917

6915

P01AB01

ATC

metronidazole; oral, rectal

1.2

15.8

3595

31814

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

15.8

348

2178

R20.2

ICD-10 Finland

Paraesthesia of skin

1.4

15.7

616

4357

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

15.7

583

4082

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

15.7

399

2584

U02

ICPC

Urinary frequency/urgency

1.3

15.7

1120

8725

D10

ICPC

Vomiting

1.4

15.7

671

4824

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

15.6

692

5003

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

15.6

1478

11941

N01

ICPC

Headache

1.3

15.6

1215

9577

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

15.6

251

1446

A05

ICPC

Feeling ill

1.4

15.5

658

4723

ZXH09, ,

SPAT

0.3

15.4

1398

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

15.4

417

2737

G47.3

ICD-10 Finland

Sleep apnoea

1.3

15.3

1696

13958

R03AC13

ATC

formoterol; inhalant

1.6

15.3

348

2195

N02AX02

ATC

tramadol; systemic, rectal

1.2

15.3

3386

29872

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

2.3

15.3

110

476

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

15.1

998

7688

G04CA02

ATC

tamsulosin; oral

1.3

15.0

1143

8979

R03AC03

ATC

terbutaline; inhalant

1.3

15.0

1156

9097

F45.8

ICD-10 Finland

Other somatoform disorders

1.4

14.9

720

5283

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.7

14.9

272

1623

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

14.8

838

6308

XLA10, ,

NOMESCO Finland

1.6

14.8

373

2411

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.0

14.7

215

WW500

NOMESCO Finland

Blood transfusion

1.7

14.7

266

1582

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

2.5

14.6

375

N06AB06

ATC

sertraline; oral

1.3

14.6

1059

8265

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.1

14.6

137

661

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.2

14.5

122

563

QBA00

NOMESCO Finland

Puncture of skin of trunk

4.3

14.5

J02AC01

ATC

fluconazole; systemic

1.2

14.5

3779

33774

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

14.4

927

7113

J46

ICD-10 Finland

Status asthmaticus

1.8

14.4

214

1205

F29

ICPC

Eye symptom/complaint other

1.4

14.3

764

5696

A01

ICPC

Pain general/multiple sites

1.4

14.3

674

4924

ZYC01, ,

SPAT

0.7

14.3

497

7056

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

14.3

1746

14521

C07AB07

ATC

bisoprolol; oral

1.2

14.3

3209

28309

J01EA01

ATC

trimethoprim; systemic

1.2

14.2

2154

18314

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

14.1

830

6284

J05AB01

ATC

aciclovir; systemic

1.2

14.0

1804

15079

-1, ,

ICD-10 Finland

1.5

14.0

476

3279

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

14.0

472

3247

R4110, ,

SPAT

0.6

14.0

258

4184

TGC00

NOMESCO Finland

Bronchial lavation

2.0

13.9

152

774

D06BB10

ATC

imiquimod; topical

1.5

13.9

394

2615

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

13.9

1445

11800

R03DC03

ATC

montelukast; oral

1.3

13.7

1441

11774

SPAT1377

SPAT

Polysomnography

0.4

13.7

1492

SPAT1387

SPAT

Health survey during first study year, university level

1.9

13.7

177

955

K01.16

ICD-10 Finland

Retained molar with obstruction in the upper jaw

1.9

13.6

169

900

B34.2

ICD-10 Finland

Coronavirus infection, unspecified site

2.6

13.6

310

S80.0

ICD-10 Finland

Contusion of knee

1.4

13.6

636

4643

R95

ICPC

Chron obstructive pulmonary disease

2.0

13.5

147

748

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

13.5

2071

17620

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

13.5

291

1813

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

13.5

335

2159

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.5

13.5

376

2487

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

13.5

2796

24469

W52

ICD-10 Finland

Crushed, pushed or stepped on by crowd or human stampede

1.9

13.5

155

805

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

13.4

631

4609

K02

ICD-10 Finland

Dental caries

0.6

13.4

275

4350

EC1VA, ,

NOMESCO Finland

0.4

13.4

1576

M79.6

ICD-10 Finland

Pain in limb

1.2

13.4

3663

32809

C09CA06

ATC

candesartan; oral

1.2

13.3

1775

14888

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

13.3

410

2771

N18.8

ICD-10 Finland

Other chronic renal failure

2.0

13.2

132

652

WE200

NOMESCO Finland

Profylactive therapy of malignancy with hormones

13.8

13.2

A10AC01

ATC

insulin (human); parenteral

1.4

13.2

522

3702

L04AD02

ATC

tacrolimus; systemic

2.5

13.2

327

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

13.1

453

3129

MATER, ,

NOMESCO Finland

40.1

13.1

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

13.1

709

5297

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.0

13.1

146

750

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.2

13.1

105

477

J01

ICD-10 Finland

Acute sinusitis

1.4

13.0

516

3658

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

13.0

1685

14088

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.6

12.9

286

1794

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

12.9

540

3869

R4120

NOMESCO Finland

Occupational therapy

1.4

12.8

480

3369

J18

ICD-10 Finland

Pneumonia, organism unspecified

2.6

12.8

284

N85.9

ICD-10 Finland

Noninflammatory disorder of uterus, unspecified

3.2

12.8

153

R74

ICPC

Upper respiratory infection acute

1.2

12.8

3479

31116

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.8

12.8

193

1093

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

12.8

387

2606

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

2.7

12.7

256

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.0

12.7

139

710

WZC30, ,

SPAT

0.5

12.6

137

2568

WVA30, ,

SPAT

0.5

12.6

120

2345

XCH00

NOMESCO Finland

Eye pressure measurement

1.6

12.6

283

1781

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

1.9

12.6

152

802

127

Kela drug reimbursment

Transplant complication

2.1

12.5

110

518

K58

ICD-10 Finland

Irritable bowel syndrome

1.7

12.5

239

1445

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

12.5

1121

8987

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.2

12.5

105

486

207

Kela drug reimbursment

Chronic arrhythmias

1.3

12.5

719

5426

SPAT1098

SPAT

Exercise ECG

2.0

12.5

125

619

F01

ICD-10 Finland

Vascular dementia

6.2

12.4

WYA10

NOMESCO Finland

Emergency care or similar visit

1.4

12.4

663

4943

R13

ICD-10 Finland

Dysphagia

1.5

12.4

442

3072

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

12.4

953

7488

L04AA06

ATC

mycophenolic acid; systemic

2.0

12.4

134

681

A10BK03

ATC

empagliflozin; oral

1.4

12.3

560

4067

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

12.3

652

4855

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

12.3

988

7808

AA1AD

NOMESCO Finland

CT of head and brain

1.2

12.3

1742

14688

EMB10

NOMESCO Finland

Tonsillectomy

1.4

12.3

624

4619

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

1.8

12.2

181

1019

A10BB12

ATC

glimepiride; oral

1.6

12.2

302

1945

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

12.2

2183

18824

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

12.2

806

6207

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

12.2

2319

20114

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

1.9

12.1

153

821

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

0.3

12.0

1165

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

12.0

533

3858

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.0

12.0

127

642

A06AD11

ATC

lactulose; oral

1.3

11.9

835

6480

B37.08

ICD-10 Finland

Other candidal stomatitis

2.7

11.9

225

M01AB05

ATC

diclofenac; systemic, rectal

1.2

11.9

6032

56402

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

0.7

11.9

440

6180

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.5

11.9

363

2450

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

11.8

3963

35961

J01MA12

ATC

levofloxacin; systemic

1.3

11.8

1210

9852

K07

ICPC

Swollen ankles/oedema

1.6

11.8

238

1460

J01FF01

ATC

clindamycin; systemic

1.2

11.8

2163

18688

X58

ICD-10 Finland

Exposure to other specified factors

1.3

11.8

1203

9791

N30.9

ICD-10 Finland

Cystitis, unspecified

1.4

11.8

456

3221

N06AB10

ATC

escitalopram; oral

1.2

11.8

2039

17526

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.4

11.7

426

2974

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.5

11.6

358

2420

H3600, E103,

ICD-10 Finland

2.1

11.6

107

514

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

11.5

981

7815

SPAT1104

SPAT

Monitoring of emergency patient

0.6

11.5

187

3125

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

11.4

372

2542

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.1

11.4

110

537

-48

ICPC

Clarification/discussion RFE/demand

0.4

11.4

1608

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

11.4

7442

70756

R07.0

ICD-10 Finland

Pain in throat

1.3

11.4

667

5048

SPAT1389

SPAT

Visit based on need for special support

1.6

11.3

276

1774

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

11.3

519

3779

SPAT1249

SPAT

Treatment-related counselling outside office

0.9

11.3

2924

32708

ZZC10

NOMESCO Finland

Allograft of fascia

15.0

11.3

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

11.3

1673

14166

SPAT1281

SPAT

Other administrative function

0.7

11.3

312

4625

N02AA05

ATC

oxycodone; systemic

1.3

11.2

975

7782

SPAT1379

SPAT

Health check-up of pregnant person

0.8

11.2

793

10103

K07.13

ICD-10 Finland

Retrognaty, mandibular

1.9

11.2

136

720

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

11.2

497

3597

SPAT1131

SPAT

Colonoscopy

0.4

11.2

1196

J01CA08

ATC

pivmecillinam; oral

1.2

11.2

3767

34158

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.1

11.2

5272

48953

M03BX02

ATC

tizanidine; oral

1.1

11.2

5854

54752

R52.9

ICD-10 Finland

Pain, unspecified

1.3

11.2

746

5753

F01.2

ICD-10 Finland

Subcortical vascular dementia

4.7

11.2

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

2.3

11.1

341

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

0.4

11.1

1192

R4190

NOMESCO Finland

Nutritional therapy

1.5

11.1

293

1917

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.8

11.1

652

8514

OAB50, ,

SPAT

0.5

11.0

133

2412

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.0

11.0

119

606

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

2.2

11.0

432

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

2.8

11.0

195

K07.60

ICD-10 Finland

Snapping jaw

1.4

11.0

480

3465

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.3

11.0

721

5546

Z94.0

ICD-10 Finland

Kidney transplant status

2.3

11.0

350

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

2.7

10.9

207

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

10.9

898

7120

O47.1

ICD-10 Finland

False labour at or after 37 completed weeks of gestation

0.5

10.9

131

2377

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

10.8

193

1147

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.6

10.8

225

U07

ICPC

Urine symptom/complaint other

1.4

10.8

477

3451

FL1AC

NOMESCO Finland

Left cardioangiography

2.2

10.8

391

J01CA02

ATC

pivampicillin; oral

1.6

10.7

261

1678

ZXD20

NOMESCO Finland

Day surgery

1.3

10.7

958

7675

WX307

NOMESCO Finland

Obstetric epidural analgesia

0.7

10.7

543

7245

A10BX02

ATC

repaglinide; oral

2.4

10.7

286

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

10.7

821

6454

FM1AD

NOMESCO Finland

CT of heart

4.0

10.6

A10AB04

ATC

insulin lispro; parenteral

1.6

10.6

249

1586

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

1.8

10.6

158

893

A10BG03

ATC

pioglitazone; oral

1.9

10.6

132

706

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.5

10.6

328

2222

R03AC12

ATC

salmeterol; inhalant

1.6

10.6

264

1707

KMAK, ,

NOMESCO Finland

1.1

10.6

5058

46943

A10AB01

ATC

insulin (human); parenteral

1.6

10.6

270

1755

R52.0

ICD-10 Finland

Acute pain

1.6

10.5

266

1724

N18.0

ICD-10 Finland

End-stage renal disease

2.5

10.4

247

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

10.4

800

6285

ZX108

NOMESCO Finland

Inhalation

2.8

10.4

184

-31

ICPC

Medical examin/health eval partial

0.6

10.4

237

3660

E66.8

ICD-10 Finland

Other obesity

1.4

10.4

483

3523

M01AC01

ATC

piroxicam; systemic, rectal

1.3

10.4

804

6323

R01AD08

ATC

fluticasone; nasal

1.2

10.4

2572

22761

C10AA05

ATC

atorvastatin; oral

1.2

10.4

2514

22210

M53.2

ICD-10 Finland

Spinal instabilities

2.4

10.4

278

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.6

10.3

255

1644

M79.1

ICD-10 Finland

Myalgia

1.2

10.3

1243

10301

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.0

10.3

104

518

O68.8

ICD-10 Finland

Labour and delivery complicated by other evidence of fetal stress

2.2

10.3

392

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

10.3

388

2731

U01

ICPC

Dysuria/painful urination

1.3

10.3

638

4871

KH2AD

NOMESCO Finland

Computed tomography examination of urinary tract stones

18.8

10.2

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

10.2

542

4039

S09.9

ICD-10 Finland

Unspecified injury of head

2.0

10.2

100

493

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.3

10.1

667

5133

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

0.5

10.1

1792

R04.2

ICD-10 Finland

Haemoptysis

1.7

10.1

181

1078

H81

ICPC

Excessive ear wax

1.2

10.1

1053

8589

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

2.3

10.1

325

R06AX27

ATC

desloratadine; oral

1.2

10.1

2825

25228

XA420

NOMESCO Finland

Extensive sleep examination

2.2

10.1

344

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

10.1

195

1186

C07AB02

ATC

metoprolol; systemic

1.2

10.1

1108

9092

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

1.8

10.0

134

733

C01DA14

ATC

isosorbide mononitrate; oral

1.3

10.0

635

4862

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.4

10.0

455

3309

MA3AE, ,

SPAT

0.1

10.0

410

R10.0

ICD-10 Finland

Acute abdomen

1.6

10.0

244

1571

XA800

NOMESCO Finland

Neuropsychological investigation

1.5

10.0

306

2070

H02.3

ICD-10 Finland

Blepharochalasis

1.4

9.9

365

2556

R35

ICD-10 Finland

Polyuria

1.4

9.9

390

2765

V03AE01

ATC

polystyrene sulfonate; oral

2.4

9.9

278

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.5

9.9

258

1686

K08.3

ICD-10 Finland

Retained dental root

1.4

9.9

477

3504

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.5

9.9

321

2197

MA5AE, ,

SPAT

0.2

9.9

424

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

9.9

802

6350

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

3.1

9.8

125

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.4

9.8

389

2762

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.2

9.8

348

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

9.8

388

2755

SPAT1360

SPAT

Extensive global examination

1.4

9.8

469

3441

I95.1

ICD-10 Finland

Orthostatic hypotension

1.7

9.8

164

960

R49.08

ICD-10 Finland

Other specified dysphonia

1.8

9.8

153

879

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.1

9.7

4490

41484

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.3

9.7

758

5967

N03AX16

ATC

[U] pregabalin

1.2

9.7

1671

14335

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.5

9.7

313

2140

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

9.7

1796

15509

D07AB01

ATC

clobetasone; topical

1.6

9.7

226

1441

TI02, ,

NOMESCO Finland

55.0

9.6

SPAT1313

SPAT

Guidance and counselling related to accident prevention

2.7

9.6

181

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.5

9.6

276

1841

A10AA01, ,

ATC

1.6

9.6

199

1233

S01.8

ICD-10 Finland

Open wound of other parts of head

2.0

9.6

105

539

B03XA02

ATC

darbepoetin alfa; parenteral

1.9

9.6

113

595

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.4

9.5

434

3157

UJH02

NOMESCO Finland

Anoscopy

1.5

9.5

271

1804

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.3

9.5

289

177

Kela drug reimbursment

Insulin glargine 300 U / ml

1.8

9.5

142

804

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

2.8

9.5

171

WX110

NOMESCO Finland

Infiltration anesthesia

1.1

9.5

7189

68526

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.4

9.5

247

F43.0

ICD-10 Finland

Acute stress reaction

1.3

9.5

552

4176

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.4

9.5

367

2597

Y25

ICPC

Fear sexually transm disease male

1.6

9.5

188

1152

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.4

9.5

379

2698

B99

ICD-10 Finland

Other and unspecified infectious diseases

1.9

9.4

118

633

R03AK08

ATC

formoterol and beclometasone; inhalant

1.5

9.4

305

2086

FP1E5

NOMESCO Finland

ECG, with computer analysis

17.5

9.4

M05BX04

ATC

denosumab; parenteral

1.5

9.4

290

1965

L82

ICD-10 Finland

Seborrhoeic keratosis

1.2

9.3

1151

9556

R73

ICD-10 Finland

Elevated blood glucose level

1.6

9.3

185

1133

G01AA10

ATC

clindamycin; vaginal

1.2

9.3

1244

10412

J01MA06

ATC

norfloxacin; oral

1.3

9.3

879

7089

W0X00

NOMESCO Finland

Estimation of continuous need for medical therapy

6.9

9.3

FM1QE

NOMESCO Finland

Extensive ultrasound of fetal heart

0.2

9.2

389

N19

ICD-10 Finland

Unspecified kidney failure

1.7

9.2

162

962

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

2.9

9.2

141

R81

ICPC

Pneumonia

1.6

9.2

216

1379

G44.2

ICD-10 Finland

Tension-type headache

1.2

9.2

1183

9866

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.6

9.2

196

1223

AN1

Coronary angiography

1.4

9.2

496

3710

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.3

9.2

307

SPAT1283

SPAT

Restricted health certificate

1.2

9.2

2024

17727

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.5

9.1

287

1951

XQ848

NOMESCO Finland

Dermatological photography

1.6

9.1

189

1171

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

1.3

9.1

834

6700

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

9.1

422

3081

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

1.8

9.1

122

670

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.0

9.1

508

EB1TW

NOMESCO Finland

3D modelling of dentition

4.0

9.0

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

1.6

9.0

193

1205

SPAT1255

SPAT

Intravenous administration of medicine

1.4

9.0

423

3094

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.6

9.0

215

1380

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

2.7

9.0

171

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.6

8.9

194

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.5

8.9

275

1866

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.8

8.9

128

719

N02BF02

ATC

pregabalin; oral

1.4

8.8

407

2968

H01

ICPC

Ear pain/earache

1.2

8.8

1049

8675

MBC10

NOMESCO Finland

Repair of obstetric laceration of vagina

0.5

8.8

1377

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.9

8.8

139

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

0.7

8.8

283

4073

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

8.8

560

4293

H57.1

ICD-10 Finland

Ocular pain

1.5

8.8

302

2092

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

8.8

411

3007

Z72.0

ICD-10 Finland

Tobacco use

1.6

8.8

197

1246

D06

ICPC

Abdominal pain localized other

1.3

8.7

720

5710

G04BD12

ATC

mirabegron; oral

1.3

8.7

631

4921

Z13.88

ICD-10 Finland

Special screening examination for other specified diseases and disorders

1.8

8.7

127

715

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.2

8.7

1018

8403

SPAT1181

SPAT

Ultrasound examination of uterus and uterine appendages

1.5

8.7

281

1921

K57

ICD-10 Finland

Diverticular disease of intestine

1.8

8.7

126

708

HAB99

NOMESCO Finland

Other partial excision of mammary gland

1.7

8.7

152

902

A12AA04

ATC

calcium carbonate; oral

2.0

8.7

413

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.2

8.7

1026

8481

H66.9

ICD-10 Finland

Otitis media, unspecified

1.3

8.7

620

4828

B01AC04

ATC

clopidogrel; oral

1.3

8.7

767

6136

D12

ICPC

Constipation

1.6

8.6

209

1345

171

Kela drug reimbursment

Degludekinsuliini

2.9

8.6

130

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

2.5

8.6

210

M01AB08

ATC

etodolac; oral

1.4

8.6

465

3481

R1420

NOMESCO Finland

Assessment of rehabilitation needs and/or compilation of rehabilitation plan

3.9

8.6

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

4.8

8.6

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

8.6

424

3130

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.2

8.6

297

SAB02

NOMESCO Finland

Oral and dental health check by dental hygienist or dental assistant

0.7

8.5

425

5681

50300

ICD-8 Finland

Chronic sinusitis, Maxillaris cum empyemate

2.9

8.5

126

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.2

8.5

1452

12442

R05FB02

ATC

cough suppressants and expectorants; systemic

1.1

8.5

2699

24279

F03

ICD-10 Finland

Unspecified dementia

1.7

8.4

138

804

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

1.2

8.4

1299

11022

A10AA02, ,

ATC

1.5

8.4

214

1393

J06.0

ICD-10 Finland

Acute laryngopharyngitis

2.0

8.4

473

XX1VW, ,

SPAT

2.2

8.4

306

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.3

8.4

632

4957

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.1

8.3

379

R06AE07

ATC

cetirizine; oral

1.1

8.3

4166

38572

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.2

8.3

1352

11528

TK800

NOMESCO Finland

Hemodialysis

1.8

8.3

116

646

K03.64

ICD-10 Finland

Dental calculus supragingival

1.1

8.3

3098

28164

J96.1

ICD-10 Finland

Chronic respiratory failure

1.9

8.3

476

A11CC03

ATC

alfacalcidol; systemic

1.7

8.2

132

765

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.5

8.2

220

1448

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.4

8.2

335

2394

R52.2

ICD-10 Finland

Other chronic pain

1.5

8.2

248

1675

SMAK, ,

NOMESCO Finland

2.3

8.2

258

NBE25

NOMESCO Finland

Suture or reinsertion of ligament of shoulder, arthroscopic

2.7

8.2

162

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.0

8.2

450

KED52

NOMESCO Finland

Visual laser resection of prostate

2.3

8.1

265

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

0.2

8.1

580

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

8.1

274

1891

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.6

8.1

162

996

SPAT1366

SPAT

Health check-up performed based on health survey in students of universities, universities of applied sciences etc.

1.4

8.1

304

2141

SPAT1097

SPAT

Recording of ECG

1.2

8.1

866

7083

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.3

8.1

439

3290

CH2X4

NOMESCO Finland

Optical coherence tomography (OCT) of iris and iridocorneal angle

8.1

K86.1

ICD-10 Finland

Other chronic pancreatitis

2.3

8.1

235

V03AE03

ATC

lanthanum carbonate; oral

3.2

8.1

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

1.7

8.0

126

726

WX892

NOMESCO Finland

Monitored bed care

1.3

8.0

451

3396

Z23.5

ICD-10 Finland

Need for immunization against tetanus alone

0.2

8.0

371

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

1.6

8.0

165

1022

WX290, ,

SPAT

1.4

8.0

314

2229

E87.6

ICD-10 Finland

Hypokalaemia

1.6

8.0

178

1124

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

2.2

8.0

293

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

1.8

8.0

103

560

R49.01

ICD-10 Finland

Functional dysphonia

1.5

8.0

202

1315

IAZ98, ,

SPAT

3.5

7.9

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.5

7.9

267

1843

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

2.1

7.9

333

K92.1

ICD-10 Finland

Melaena

1.4

7.9

281

1959

ZX120

NOMESCO Finland

Intravenous

1.3

7.9

606

4763

H92.0

ICD-10 Finland

Otalgia

1.3

7.9

516

3971

L23.4

ICD-10 Finland

Allergic contact dermatitis due to dyes

4.4

7.9

38402

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita

2.1

7.9

354

EB1A, ,

NOMESCO Finland

7.7

7.9

N05AA02

ATC

levomepromazine; systemic

1.5

7.9

254

1740

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

7.9

165

1028

N02AJ06

ATC

codeine and paracetamol; systemic

1.1

7.8

3679

33895

M01AE02

ATC

naproxen; oral, rectal

1.1

7.8

5408

50959

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.3

7.8

463

3514

NH3EA

NOMESCO Finland

Feet X-ray examination with load

0.3

7.8

798

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

2.0

7.8

410

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.1

7.8

2287

20440

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

7.8

311

2218

PD4HE

NOMESCO Finland

Postoperative lower extremity artery ultrasound examination with Doppler method

6.9

7.7

RF210, ,

NOMESCO Finland

0.5

7.7

1338

R06AX13

ATC

loratadine; oral

1.2

7.7

1345

11540

O26.7

ICD-10 Finland

Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium

1.8

7.7

102

560

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.3

7.7

439

3316

C03DA01

ATC

spironolactone; oral

1.3

7.7

626

4963

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

7.6

1110

9366

ZXD40

NOMESCO Finland

Procedure on patient requiring isolation

3.3

7.6

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.2

7.6

1019

8529

N06AA10

ATC

nortriptyline; systemic

1.7

7.6

140

844

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.1

7.6

319

TI01, ,

NOMESCO Finland

18.3

7.6

D05AX52

ATC

calcipotriol, combinations; topical

1.4

7.6

354

2592

F41.3

ICD-10 Finland

Other mixed anxiety disorders

1.6

7.6

156

968

S01XA18

ATC

ciclosporin; ophthalmic

2.3

7.5

236

K03.00

ICD-10 Finland

Approximal wear

1.3

7.5

551

4307

W12

ICPC

Contraception intrauterine

1.2

7.5

1058

8899

J30.3

ICD-10 Finland

Other allergic rhinitis

1.4

7.5

300

2138

V19

ICD-10 Finland

Pedal cyclist injured in other and unspecified transport accidents

1.6

7.5

162

1018

O48

ICD-10 Finland

Prolonged pregnancy

0.6

7.5

147

2335

TKC22

NOMESCO Finland

Catheterisation instruction

1.8

7.4

110

624

R07.1

ICD-10 Finland

Chest pain on breathing

1.8

7.4

110

624

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.4

7.4

285

2017

LAA06

NOMESCO Finland

Transvaginal puncture of ovarian cyst

2.2

7.4

289

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.5

7.4

197

1297

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

7.4

380

2824

K07.14

ICD-10 Finland

Retrognaty, maxillary

2.6

7.4

165

MAC02

NOMESCO Finland

Rupture of aminiotic membrane for advancement of labor

0.2

7.4

312

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

2.5

7.4

171

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

7.4

637

5084

WX723

NOMESCO Finland

CPAP therapy

0.6

7.4

109

1857

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

1.8

7.4

546

SAA04

NOMESCO Finland

Special examination of mouth

1.3

7.4

410

3086

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.4

7.4

266

1863

WW200, ,

SPAT

1.2

7.3

1700

14923

K10.3

ICD-10 Finland

Alveolitis of jaws

1.3

7.3

407

3061

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

1.7

7.3

113

649

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

0.5

7.3

1353

SGC40

NOMESCO Finland

Preparing and restoring tooth to enable root canal treatment

1.6

7.3

163

1031

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.5

7.3

203

1349

H53.2

ICD-10 Finland

Diplopia

1.5

7.3

193

1269

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.6

7.3

156

978

W44

ICD-10 Finland

Foreign body entering into or through eye or natural orifice

1.7

7.2

121

712

U05

ICPC

Urination problems other

1.4

7.2

269

1896

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

0.5

7.2

1384

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.5

7.2

244

1689

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.4

7.2

307

2216

QAA99

NOMESCO Finland

Other local destruction of skin of head or neck

3.7

7.2

WYA30, ,

SPAT

2.2

7.2

248

TDA90, ,

SPAT

0.6

7.2

130

2104

S33.5

ICD-10 Finland

Sprain and strain of lumbar spine

1.9

7.1

409

M54.8

ICD-10 Finland

Other dorsalgia

1.4

7.1

324

2363

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.3

7.1

533

4181

SCB02

NOMESCO Finland

Instructions for self-performed oral hygiene

2.9

7.1

106

Y94.0

ICD-10 Finland

Accident at home

1.7

7.1

109

627

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

8.8

7.0

TBA20

NOMESCO Finland

Aspiration cytology of thyroid gland

8.8

7.0

A41.8

ICD-10 Finland

Other specified sepsis

1.9

7.0

482

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.2

7.0

731

5962

CKC12

NOMESCO Finland

Photocoagulation of retina

1.4

7.0

246

1715

205

Kela drug reimbursment

Chronic hypertension

1.2

7.0

1300

11211

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.5

7.0

198

1323

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.4

7.0

297

2143

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

3.9

7.0

XCK00

NOMESCO Finland

Perimetry

1.4

7.0

349

2586

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.3

6.9

412

3131

I20.09

ICD-10 Finland

Unstable angina

1.4

6.9

240

1668

W49

ICD-10 Finland

Exposure to other and unspecified inanimate mechanical forces

1.7

6.9

117

690

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.6

6.9

138

850

EBA10

NOMESCO Finland

Operative extraction of tooth

1.2

6.9

1350

11687

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

6.9

628

5044

SPAT1044

SPAT

Tympanometry

1.6

6.9

161

1030

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

1.8

6.9

103

587

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.1

6.9

272

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.5

6.9

172

1119

U72

ICPC

Urethritis

1.6

6.8

165

1064

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

0.7

6.8

234

3323

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.5

6.8

169

1098

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.7

6.8

125

755

Z10.0

ICD-10 Finland

Occupational health examination

0.8

6.8

538

6756

SCA02

NOMESCO Finland

Preventive oral health care

0.8

6.8

657

8064

A10AD05

ATC

insulin aspart; parenteral

1.9

6.8

410

J01FA10

ATC

azithromycin; systemic

1.1

6.8

5772

54835

K59.1

ICD-10 Finland

Functional diarrhoea

1.3

6.8

361

2702

64199

ICD-8 Finland

Abortion induced for other legal indications, Without mention of sepsis or toxaemia

0.6

6.7

149

2305

W06

ICD-10 Finland

Fall involving bed

2.6

6.7

149

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

6.7

221

1521

EB4VA, ,

NOMESCO Finland

0.8

6.7

652

8004

N76.0

ICD-10 Finland

Acute vaginitis

1.2

6.7

655

5304

L12

ICPC

Hand/finger symptom/complaint

1.2

6.7

1301

11257

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

3.1

6.7

B37.4

ICD-10 Finland

Candidiasis of other urogenital sites

2.9

6.7

104

R03AK11

ATC

formoterol and fluticasone; inhalant

1.5

6.7

166

1077

J01.1

ICD-10 Finland

Acute frontal sinusitis

1.6

6.7

129

788

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

1.2

6.7

678

5513

X57

ICD-10 Finland

Unspecified privation

1.6

6.7

154

983

D22

ICD-10 Finland

Melanocytic naevi

1.3

6.7

461

3579

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

2.8

6.7

110

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.2

6.6

734

6027

EBA40

NOMESCO Finland

Extraction of apex of root of tooth

1.9

6.6

420

G01AF05

ATC

econazole; vaginal

1.3

6.6

567

4525

CG2T4

NOMESCO Finland

Topography assessment of cornea

2.1

6.6

290

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

1.7

6.6

113

670

SPAT1189

SPAT

Other ultrasound examination during pregnancy

0.6

6.6

151

2316

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

6.6

1402

12224

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.3

6.6

357

2679

SPF20

NOMESCO Finland

Temporary relining of dentures

2.2

6.6

225

G04CB02

ATC

dutasteride; oral

1.4

6.6

295

2149

L43.8

ICD-10 Finland

Other lichen planus

1.8

6.6

559

E10

ICD-10 Finland

Type 1 diabetes mellitus

1.6

6.5

150

957

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

3.2

6.5

L57.0

ICD-10 Finland

Actinic keratosis

1.3

6.5

464

3616

OAB42

NOMESCO Finland

Guidance related to known health problem

3.3

6.5

D01AE16

ATC

amorolfine; topical

1.2

6.5

712

5838

KAY20, ,

NOMESCO Finland

1.4

6.5

239

1680

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.4

6.5

299

2185

M02AA07

ATC

piroxicam; topical

1.1

6.5

2475

22463

N06AX21

ATC

duloxetine; oral

1.2

6.5

907

7622

XX9TB

NOMESCO Finland

Complementary X-ray examination with contrast

3.8

6.5

A10BH02

ATC

vildagliptin; oral

1.8

6.5

502

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.3

6.5

434

3356

K25

ICPC

Fear of hypertension

1.5

6.5

210

1443

H53.1

ICD-10 Finland

Subjective visual disturbances

1.3

6.5

476

3728

TQB05

NOMESCO Finland

Puncture of skin of trunk

2.0

6.5

340

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.4

6.4

281

2037

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.4

6.4

256

1827

L15

ICPC

Knee symptom/complaint

1.1

6.4

1777

15794

C07AG02

ATC

carvedilol; oral

1.4

6.4

268

1929

I84

ICD-10 Finland

Hemorrhoids

1.5

6.4

169

1113

R51

ICD-10 Finland

Headache

1.3

6.4

483

3794

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.3

6.4

570

4571

T89

ICPC

Diabetes insulin dependent

1.4

6.4

292

2135

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.3

6.4

349

2624

TQW40, ,

SPAT

0.7

6.4

279

3798

ZX080

NOMESCO Finland

Image guided radiotherapy

0.4

6.3

764

J16.8

ICD-10 Finland

Pneumonia due to other specified infectious organisms

4.1

6.3

XMA20

NOMESCO Finland

Early examination of pregnancy

0.3

6.3

587

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.5

6.3

180

1205

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

2.3

6.3

197

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

2.3

6.3

197

H66

ICD-10 Finland

Suppurative and unspecified otitis media

1.5

6.3

210

1451

QDA50

NOMESCO Finland

Cryotherapy of skin of lower limb

3.6

6.3

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.4

6.3

280

2037

3025

Kela drug reimbursment

Calcium carbonate

2.6

6.3

125

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

1.5

6.3

164

1078

SBB10

NOMESCO Finland

Dental impressions

1.3

6.3

592

4778

D64.8

ICD-10 Finland

Other specified anaemias

1.8

6.3

501

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.1

6.3

243

D06BB03

ATC

aciclovir; topical

1.4

6.3

318

2364

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

6.2

3224

29782

L05

ICPC

Flank/axilla symptom/complaint

1.3

6.2

391

2997

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

1.2

6.2

1004

8551

C07AA05

ATC

propranolol; systemic

1.1

6.2

1753

15597

R41.0

ICD-10 Finland

Disorientation, unspecified

1.6

6.2

133

835

M03BC01

ATC

orphenadrine (citrate); systemic

1.1

6.2

1901

17009

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.5

6.2

211

1463

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.3

6.2

418

3235

F51.0

ICD-10 Finland

Nonorganic insomnia

1.2

6.2

1462

12842

M15

ICD-10 Finland

Polyarthrosis

1.4

6.2

256

1839

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

1.5

6.2

156

1018

120

Kela drug reimbursment

Hypogammaglobulinaemia

3.7

6.2

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.7

6.2

577

T18.1

ICD-10 Finland

Foreign body in oesophagus

2.0

6.2

291

CA1ME

NOMESCO Finland

Ultrasound oculometry

2.5

6.2

144

Z01.2

ICD-10 Finland

Dental examination

1.1

6.2

4401

41353

T82

ICPC

Obesity

1.4

6.1

320

2388

A04AA01

ATC

ondansetron; systemic, rectal

1.3

6.1

498

3949

WXQ99

NOMESCO Finland

Other light therapy

5.7

6.1

-30

ICPC

Medical examin/health eval complete

0.7

6.1

168

2480

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

2.5

6.1

139

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

2.4

6.1

157

J03

ICD-10 Finland

Acute tonsillitis

1.4

6.1

262

1897

F50.2

ICD-10 Finland

Bulimia nervosa

1.9

6.1

383

I50.0

ICD-10 Finland

Congestive heart failure

1.4

6.1

257

1856

O42.9

ICD-10 Finland

Premature rupture of membranes, unspecified

0.7

6.0

147

2224

VALMI, ,

NOMESCO Finland

1.1

6.0

2284

20715

K04.08

ICD-10 Finland

Other specified pulpit

1.2

6.0

672

5525

WX111

NOMESCO Finland

Local infiltration anesthesia

1.5

6.0

170

1137

K07.24

ICD-10 Finland

Open bite

1.7

6.0

107

642

WGA11

NOMESCO Finland

Planning of pain management

2.5

6.0

140

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1195

3724

3.48

312.57

3.0

2.5

0.20

0.24

e6/l

0.40

1159

3588

(3014576) Chloride [Moles/volume] in Serum or Plasma

2294

8321

3.22

307.65

5.7

6.7

105.02

104.53

mmol/l

5.23

2289

8314

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

10632

70830

14.49

307.65

4.5

3.4

—

(3002032) Base excess in Venous blood by calculation

2584

5985

5.33

307.65

4.5

4.1

2.03

1.79

mmol/l

3.04

2225

5007

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1053

546

21.21

307.65

2.3

—

(3008037) Lactate [Moles/volume] in Venous blood

1727

1052

19.27

307.65

3.5

2.8

1.45

1.59

mmol/l

3.42

1719

1020

(3024354) Oxygen [Partial pressure] in Venous blood

2400

4884

6.00

307.65

4.1

3.6

4.41

4.73

kpa

10.82

2376

4706

(3026782) Osmolality of Urine

3686

15220

3.13

307.65

4.4

2.6

575.94

542.17

mosm/kgh2o

2.17

3303

12982

(1761482) Bacteria [#/volume] in Urine by Culture

2133

1242

21.05

307.65

5.0

3.6

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2583

6014

5.30

307.65

4.5

4.1

5.73

5.85

kpa

7.84

2560

5812

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4933

29163

2.25

307.65

3.1

28.58

33.11

u/l

5.02

4754

27751

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1377

2440

6.30

307.65

3.2

5.2

1.41

1.74

17.49

1368

2245

(3015736) pH of Urine

5616

35504

2.18

307.65

4.4

3.0

5.97

5.93

0.28

278

3586

(3027273) Bicarbonate [Moles/volume] in Venous blood

1974

2784

8.42

307.65

3.9

3.5

25.61

25.07

mmol/l

8.53

1959

2684

(3038515) Glucose [Moles/volume] in Venous blood

1717

966

20.86

307.65

3.5

2.9

7.19

7.61

mmol/l

3.27

1710

939

(3000330) Specific gravity of Urine by Test strip

2492

3240

9.64

307.65

5.2

2.7

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1365

2864

5.30

307.65

2.8

3.1

0.74

0.65

18.89

1356

2850

(3013512) EKG study

4300

20452

2.81

307.65

5.1

3.3

—

(3035285) Chloride [Moles/volume] in Venous blood

1053

570

20.32

307.65

2.3

106.22

105.20

mmol/l

4.93

1045

563

(3041354) Potassium [Moles/volume] in Venous blood

1053

570

20.32

307.65

2.3

3.99

4.03

mmol/l

1.23

1045

563

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1346

4101

3.60

307.65

1.7

1.4

—

(3012544) pH of Venous blood

2571

6219

5.09

307.65

4.5

4.1

7.36

7.37

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2081

3713

6.67

307.65

3.8

3.5

134.75

130.79

g/l

11.70

2067

3619

(3021589) Normoblasts [#/volume] in Blood

6372

38824

2.52

307.65

9.6

8.5

0.00

e9/l

0.10

5483

31851

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1950

2547

9.08

307.65

5.3

3.7

44.07

50.33

16.29

1941

2515

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1377

2923

5.24

307.65

2.8

3.1

1.12

1.32

6.86

1365

2904

(3007930) Methemoglobin/Hemoglobin.total in Blood

1378

2401

6.41

307.65

3.2

5.3

0.79

0.91

25.63

1369

2211

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2679

12945

2.41

307.15

3.2

2.5

1.25

1.13

e6/l

0.62

1806

7137

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

671

1479

4.77

282.40

1.7

2.3

0.76

0.83

nmol/l

2.06

550

1262

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2486

12058

2.37

279.38

3.3

2.6

3.79

3.27

e6/l

0.60

1618

6283

(3026008) Bacteria identified in Urine by Culture

4054

24043

2.08

275.08

3.7

2.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3266

18772

2.05

233.59

2.1

1.7

0.98

1.04

mg/l

0.47

2564

13773

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5404

37611

1.86

212.40

8.2

6.0

1.21

1.22

mmol/l

0.66

5079

31908

(3003338) MCHC [Mass/volume]

9680

82262

2.43

206.78

20.2

14.1

332.73

333.01

g/l

2.44

9632

81633

(3041096) Erythrocytes [Presence] in Urine by Automated

3899

24819

1.88

200.27

4.7

2.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

5984

43702

1.81

194.03

7.9

4.3

0.00

estimate

2.81

440

8712

(3009261) Glucose [Presence] in Urine by Test strip

6021

44055

1.81

193.98

4.7

3.3

0.00

estimate

2.43

430

8481

(3018010) Neutrophils/100 leukocytes in Blood

5855

42567

1.80

191.92

7.4

5.7

57.19

56.32

7.17

5572

40163

(3035350) Ketones [Presence] in Urine by Test strip

5971

43690

1.80

191.25

4.6

3.2

0.01

0.00

estimate

1.16

616

8936

(3022096) Basophils/100 leukocytes in Blood

5541

39819

1.79

187.14

7.7

5.9

0.64

0.68

9.12

5210

37255

(3006504) Eosinophils/100 leukocytes in Blood

5687

41263

1.78

185.06

7.6

5.8

2.70

2.86

6.46

5379

38754

(3019069) Monocytes/100 leukocytes in Blood

5711

41499

1.78

184.78

7.8

6.1

8.23

8.29

0.79

5408

39063

(3002030) Lymphocytes/100 leukocytes in Blood

5892

43216

1.78

184.48

7.6

5.8

28.32

29.30

10.04

5605

40800

(3023368) Bacteria identified in Blood by Culture

3065

18513

1.91

181.65

5.2

3.9

—

(3013115) Eosinophils [#/volume] in Blood

6134

45668

1.77

180.93

7.7

6.0

0.19

e9/l

1.17

5476

40626

(3001604) Monocytes [#/volume] in Blood

5956

43969

1.77

180.92

7.4

5.8

0.57

0.56

e9/l

1.10

5313

38585

(3006315) Basophils [#/volume] in Blood

5955

44070

1.76

178.27

7.4

5.8

0.04

e9/l

0.87

5315

38611

(3019198) Lymphocytes [#/volume] in Blood

6125

45743

1.76

177.11

7.4

5.7

1.97

1.98

e9/l

0.02

5513

41062

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

531

1396

3.95

176.47

1.1

226.07

7145.72

iu/ml

0.62

377

(3013650) Neutrophils [#/volume] in Blood by Automated count

6628

50773

1.76

173.88

10.4

8.5

4.11

4.01

e9/l

2.97

5972

44534

(3002385) Erythrocyte distribution width [Ratio]

9399

80642

2.11

167.47

20.4

13.4

14.23

14.73

0.61

9354

79246

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4451

30765

1.75

165.45

2.1

1.8

96.65

97.41

pmol/l

0.57

2602

16378

(3013826) Glucose [Moles/volume] in Serum or Plasma

6271

47809

1.72

162.11

5.6

4.2

6.70

6.49

mmol/l

10.06

5768

43750

(1761868) Lipid panel - Serum or Plasma

4901

34964

1.72

161.36

4.6

2.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3562

23323

1.78

158.23

1.9

1.7

—

(3018095) Leukocytes [#/volume] in Urine

4223

29091

1.73

156.43

4.3

3.3

100.64

82.93

e6/l

0.33

2921

19690

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1060

4496

2.50

153.84

1.3

239.52

226.65

miu/ml

0.51

500

2218

(3037467) Urinalysis macro (dipstick) panel - Urine

7546

61167

1.74

150.04

5.7

3.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

1314

6355

2.21

140.41

5.0

4.1

0.08

0.13

1.48

353

1698

(3030467) Casts [#/volume] in Urine by Automated count

3306

21827

1.73

138.82

3.7

2.8

0.32

0.38

e6/l

0.35

2599

16294

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1252

5988

2.23

137.34

3.6

3.5

1.23

mmol/l

2.15

1201

5203

(3002179) Metamyelocytes/100 leukocytes in Blood

1269

6108

2.22

137.03

4.7

3.9

0.71

0.63

0.48

296

1718

(40760892) CBC W Ordered Manual Differential panel - Blood

5481

41446

1.64

136.04

8.1

6.1

—

(3017181) Myelocytes/100 leukocytes in Blood

1339

6634

2.16

134.31

5.1

4.1

0.82

0.90

0.41

378

1974

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5485

41666

1.63

132.20

6.4

5.6

10.23

10.99

umol/l

6.27

5229

39331

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3930

27460

1.67

132.13

4.2

3.0

46.40

70.48

ng/l

0.40

2479

15457

(3002582) Erythrocytes [#/volume] in Urine

3508

23893

1.69

129.42

3.8

2.9

49.70

74.88

e6/l

1.37

2717

18063

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9481

83514

1.96

128.46

15.1

10.0

87.33

88.85

ml/min/173m2

8.87

8221

68250

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4666

34260

1.63

127.58

4.9

3.3

—

(3025159) Blasts/100 leukocytes in Blood

1234

6067

2.16

125.77

5.0

4.2

0.08

0.26

1.08

263

1412

(3013707) Erythrocyte sedimentation rate by Westergren method

7727

64912

1.63

114.91

4.2

3.7

10.97

10.27

mm/h

4.66

7331

60616

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

713

2886

2.57

113.15

1.6

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7641

64240

1.62

110.94

3.4

2.9

40.38

41.10

u/l

0.41

7334

60854

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

10094

91934

2.14

109.17

18.2

11.2

21.50

21.27

mg/l

0.28

8325

70810

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1330

7094

1.99

107.93

2.1

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

575

2174

2.74

104.47

2.1

1.9

1.36

2.17

ug/l

1.56

523

1936

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1339

7243

1.97

104.12

2.1

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

9433

84281

1.82

103.72

5.4

4.6

1.85

2.00

mu/l

1.62

9105

78802

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1822

10920

1.80

102.73

2.3

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

651

2658

2.54

101.24

1.3

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

3724

27012

1.57

100.26

2.5

2.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2568

17113

1.65

97.93

3.3

2.8

1252.58

1146.39

ng/l

0.51

2267

14230

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

809

3700

2.28

97.57

2.6

2.3

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7579

64505

1.56

95.68

8.5

6.8

77.10

75.47

u/l

2.45

7301

60890

(3013139) Helicobacter pylori Ag [Presence] in Stool

1125

5937

2.00

93.37

1.3

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1354

7691

1.87

89.97

4.7

4.2

240.20

236.66

u/l

0.34

1311

7249

(40761511) CBC panel - Blood by Automated count

10390

96775

2.25

88.62

15.6

10.5

—

(3000991) Gas panel - Venous blood

1090

5817

1.97

87.33

9.7

8.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

9799

89638

1.83

85.26

18.7

12.0

139.78

139.61

mmol/l

10.44

9654

87240

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1781

11171

1.71

83.96

2.2

2.1

29.63

29.59

0.12

1745

10796

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

508

2033

2.57

82.12

1.6

1.4

19.59

9.57

iu/ml

0.64

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9290

83937

1.67

81.76

4.1

3.4

1.23

1.26

mmol/l

4.20

8920

78595

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1758

11087

1.70

80.94

2.9

2.3

2.42

2.41

g/l

0.14

1657

10279

(3042936) Bacteria identified in Isolate by Culture

1730

10918

1.69

79.29

2.2

1.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

9794

89938

1.79

79.17

18.8

12.1

3.92

3.94

mmol/l

5.58

9625

87327

(3009542) Hematocrit [Volume Fraction] of Blood

10853

103784

3.67

77.09

25.4

16.7

39.12

40.69

29.81

10469

98500

(3000963) Hemoglobin [Mass/volume] in Blood

10869

104046

3.85

76.76

25.3

16.7

134.80

135.99

g/l

16.78

10835

102838

(3035941) MCH [Entitic mass]

10864

103986

3.78

76.38

25.0

16.5

30.04

30.13

7.53

10819

102771

(3010813) Leukocytes [#/volume] in Blood

10866

104020

3.80

76.31

25.1

16.6

6.78

6.70

e9/l

2.68

10727

101422

(3026361) Erythrocytes [#/volume] in Blood

10864

104008

3.76

75.90

25.1

16.6

4.51

4.53

e12/l

5.84

10738

101459

(3024731) MCV [Entitic volume]

10863

103993

3.75

75.89

25.0

16.6

90.03

90.27

7.38

10816

102778

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9274

84173

1.64

75.19

4.6

3.8

5.93

5.75

mmol/l

30.01

8925

78106

(3022948) Iron [Moles/volume] in Serum or Plasma

1866

12186

1.64

74.47

2.9

2.3

13.12

14.00

umol/l

5.81

1773

11414

(3007164) IgA [Mass/volume] in Serum or Plasma

2752

19675

1.53

74.34

1.5

1.4

2.21

2.26

g/l

0.71

1748

12508

(3007461) Platelets [#/volume] in Blood

10851

103894

3.57

74.06

25.1

16.6

258.92

258.52

e9/l

0.27

10733

101543

(3020682) Albumin/Creatinine [Ratio] in Urine

2880

20832

1.52

73.50

4.4

3.9

7.63

9.88

mg/mmol

2.21

2265

13370

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3414

25656

1.48

71.94

2.8

2.5

55.86

61.65

u/l

1.04

3234

23759

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9505

87036

1.66

71.64

4.4

3.8

1.46

1.47

mmol/l

3.65

9175

81942

(3024561) Albumin [Mass/volume] in Serum or Plasma

4261

33475

1.44

70.92

5.1

4.6

36.24

36.37

g/l

0.87

4064

31198

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10315

96800

2.00

70.40

11.5

8.9

25.78

26.41

u/l

2.44

10142

93826

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9546

87592

1.66

70.33

4.4

3.8

4.61

4.74

mmol/l

34.52

9219

82715

(3005322) IgE [Units/volume] in Serum or Plasma

1128

6513

1.82

70.10

1.4

1.3

172.31

227.11

u/ml

1.53

1030

6032

(3048689) Calprotectin [Mass/mass] in Stool

1930

12878

1.60

70.10

2.5

103.18

119.39

ug/g

1.78

1594

10182

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8139

72108

1.49

69.96

4.4

4.0

14.68

14.52

pmol/l

8.34

7705

66563

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2827

20554

1.50

69.72

2.5

2.2

2.92

2.80

mg/l

1.94

2457

17652

(40758558) Short blood count panel - Blood

2935

21533

1.49

69.15

7.1

6.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9627

88632

1.67

68.71

4.8

4.1

2.78

2.84

mmol/l

11.88

9311

83254

(3036603) Volume of Urine

185

457

4.10

66.80

1.6

1.5

2068.08

2025.05

0.24

177

448

(3027945) Reticulocytes/100 erythrocytes in Blood

1236

7439

1.74

66.47

2.8

2.6

1.76

1.72

0.72

1129

6587

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

377

1461

2.64

64.98

1.2

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5107

41971

1.40

63.60

2.9

2.4

—

(3000494) Fungus identified in Specimen by Culture

1518

9766

1.64

63.38

1.6

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

688

3494

2.03

62.78

1.9

1.5

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1778

11941

1.58

62.04

4.1

3.3

0.82

mmol/l

1.43

1677

11213

(3004775) Volume in Urine collected for unspecified duration

189

506

3.78

61.03

1.9

2.3

631.43

633.26

0.02

364

(3038177) Helicobacter pylori Ab [Presence] in Serum

413

1724

2.45

60.92

1.3

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

370

1471

2.57

60.53

1.4

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5261

43759

1.39

59.42

3.3

2.8

108.80

93.35

ug/l

5.31

5075

41158

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

399

1662

2.45

59.12

1.2

1.1

8.32

10.89

au/ml

0.53

108

(3021960) Folate [Moles/volume] in Serum or Plasma

2307

16577

1.50

58.61

1.6

1.5

20.87

20.42

nmol/l

0.74

2107

14436

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

478

2167

2.26

58.37

2.3

2.2

10.05

10.18

g/l

0.23

437

1956

(3033658) Prothrombin time (PT) actual/Normal

2771

20683

1.45

57.87

4.8

3.6

94.29

93.42

1.05

2710

20107

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1544

10201

1.60

57.36

3.1

2.4

22.03

23.68

4.87

1430

8812

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

665

3456

1.98

56.75

6.4

4.5

23.99

24.11

mmol/l

0.41

657

3387

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3010

22925

1.43

56.02

1.3

1.59

1.68

u/ml

0.14

847

6382

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

329

1285

2.61

55.81

1.6

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2947

22385

1.43

55.58

2.6

2.0

186.85

201.69

u/l

0.34

2796

21082

(3014111) Lactate [Moles/volume] in Serum or Plasma

1000

5952

1.75

55.44

7.9

6.6

1.33

1.35

mmol/l

0.18

983

5807

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4381

35756

1.37

53.62

2.6

2.2

75.16

74.80

nmol/l

0.39

4105

32923

(3023520) Reticulocytes [#/volume] in Blood

906

5294

1.77

53.48

2.7

2.6

71.49

70.19

e9/l

0.44

671

3936

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

904

5285

1.77

53.26

1.9

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

416

1870

2.27

51.81

1.4

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

485

2333

2.13

51.04

2.3

2.1

7.33

7.27

g/l

0.30

450

2134

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

484

2329

2.13

50.88

2.3

2.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

127

291

4.40

50.68

3.2

3.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

483

2328

2.12

50.56

2.3

2.1

3.71

3.65

g/l

0.28

449

2132

(3009445) Proteinase 3 Ab [Units/volume] in Serum

616

3261

1.94

49.71

1.7

1.6

8.00

11.97

u/ml

0.61

110

(3037522) Nuclear Ab [Titer] in Serum

1842

13034

1.50

49.42

1.5

1.4

654.42

536.78

titre

1.28

344

2581

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

650

3511

1.90

49.37

1.9

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

1476

9976

1.55

49.07

1.9

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

989

6074

1.69

48.66

10.1

7.2

9.39

8.67

mmol/l

2.47

947

5804

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1189

7665

1.62

48.36

2.8

2.4

31.70

43.03

u/l

1.11

1048

6580

(46235355) HIV 1 and 2 tests - Meaningful Use set

3282

25898

1.38

48.12

2.3

2.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

186

578

3.26

47.87

4.2

3.8

—

(3022217) INR in Platelet poor plasma by Coagulation assay

4057

33172

1.35

47.22

14.6

11.3

1.24

1.18

inr

2.51

822

10321

(3029937) Albumin [Presence] in Urine by Test strip

1703

23536

0.67

47.16

4.5

3.6

0.00

estimate

3.67

425

8448

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1884

13575

1.47

45.77

1.5

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

858

5182

1.71

44.79

2.7

2.4

66.44

67.04

g/l

1.49

799

4765

(3005719) IgG [Mass/volume] in Serum or Plasma

1034

6579

1.63

44.16

3.0

2.5

10.37

10.57

g/l

0.87

989

6012

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2173

16181

1.43

44.07

1.8

1.6

17824867.59

28756660.95

pmol/l

0.60

1857

13837

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

614

3376

1.87

44.06

10.0

8.9

24.43

24.17

mmol/l

1.17

594

3279

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

508

2639

1.97

43.26

1.5

1.6

204.00

324.00

titre

0.81

120

(3025941) Bacteria identified in Stool by Culture

897

5566

1.67

42.22

1.3

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

484

2495

1.98

42.13

2.9

2.7

3.90

3.49

g/l

5.22

458

2358

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

337

1513

2.27

42.10

1.5

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

337

1514

2.26

42.03

1.5

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1380

9485

1.52

42.00

8.5

5.6

1.06

1.05

mmol/l

1.36

1305

8873

(3029634) Reagin Ab [Titer] in Serum by VDRL

342

1558

2.23

41.25

2.2

1.9

3.90

8.42

titre

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1761

12761

1.45

41.07

1.7

944.55

1173.66

nmol/l

26.88

1425

9864

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

842

5186

1.68

40.74

5.1

3.8

94.76

84.38

ng/l

2.04

708

4587

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8427

77516

1.37

40.56

7.1

4.7

39.91

38.44

mmol/mol

33.13

7998

72841

(3036489) Thrombin time

581

3246

1.83

39.57

2.2

20.94

21.08

0.25

521

2749

(40761536) Microorganisms panel - Urine sediment

419

7887

0.51

39.47

5.3

3.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

299

1314

2.31

39.29

1.8

1.7

3034.67

2183.83

titre

0.28

(3006270) Folate [Moles/volume] in Blood

185

655

2.86

38.05

1.1

397.05

383.83

nmol/l

0.25

605

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

536

2961

1.85

37.84

1.9

1.8

1.55

1.43

g/l

2.02

474

2518

(3004809) Band form neutrophils/100 leukocytes in Blood

261

1108

2.39

37.14

3.2

1.35

1.55

0.39

225

999

(3048929) Epstein Barr virus Ab [Presence] in Serum

646

3867

1.71

34.65

1.3

—

(21494755) Public health laboratory ask at order entry panel

844

12725

0.64

34.19

1.2

1.3

—

(44813793) Dust mix specific IgE antibody measurement

193

739

2.64

34.19

1.2

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

261

1163

2.27

33.25

1.3

29.72

52.77

u/ml

1.02

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

961

6461

1.53

31.97

2.4

2.3

17.63

22.58

au/ml

0.82

605

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

900

5969

1.55

31.85

1.3

51.12

51.61

au/ml

0.02

309

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

463

2586

1.82

31.53

2.6

177.47

175.17

0.23

429

2455

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

868

5740

1.56

31.09

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

332

1675

2.01

30.74

3.1

23.09

25.66

mg/l

0.79

248

992

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

253

1158

2.21

30.24

1.6

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

266

1245

2.16

30.07

4.6

2.8

32085.24

1335.92

u/ml

0.46

(3003694) ABO and Rh group [Type] in Blood

3457

28983

1.28

29.61

1.5

1.6

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

476

2752

1.76

28.86

1.9

1.8

0.23

g/l

0.11

459

2609

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

209

902

2.34

28.73

1.6

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

419

2348

1.82

28.23

1.1

5.27

6.22

u/ml

0.46

207

1264

(3027801) Oxygen [Partial pressure] in Arterial blood

1050

7371

1.47

28.18

7.9

6.9

12.04

13.10

kpa

8.52

998

7023

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1050

7373

1.47

28.14

7.9

6.9

5.03

5.07

kpa

0.52

999

7024

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

385

2110

1.85

27.88

1.6

1.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

643

4066

1.62

27.83

10.2

8.5

1.32

1.40

0.95

629

4041

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

642

4065

1.62

27.64

10.3

8.6

0.65

0.69

1.62

627

4038

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

479

2815

1.73

27.42

2.4

96.23

93.72

1.73

454

2703

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

480

2845

1.72

26.65

1.9

1.8

1.19

1.17

g/l

0.49

463

2704

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

370

2036

1.85

26.46

1.3

45.17

41.60

u/ml

0.09

196

(3028026) IgM [Mass/volume] in Serum or Plasma

766

5108

1.54

26.32

2.1

1.8

1.45

1.30

g/l

0.61

718

4718

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1760

13655

1.34

26.17

4.2

3.2

247.73

526.44

ng/l

2.24

1245

9037

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1146

8295

1.43

26.02

2.3

2.1

368.43

376.16

nmol/l

0.79

1073

7614

(4034850) Laboratory test

2779

0.35

26.00

7.0

8.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

162

4.22

25.98

1.1

1.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

132

480

2.77

25.96

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

397

2247

1.80

25.89

1.1

1.03

1.30

u/ml

0.29

175

979

(3011412) CD3 cells [#/volume] in Blood

196

863

2.29

25.77

2.2

2.6

1.18

1.26

e9/l

0.64

165

763

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

366

2029

1.83

25.56

1.4

1.3

249.57

261.54

u/ml

0.38

241

1291

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

345

1879

1.86

25.50

1.3

2.71

4.28

u/ml

0.53

133

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

383

2156

1.80

25.44

1.4

1.2

—

(3003396) Base excess in Arterial blood by calculation

1034

7375

1.44

25.42

8.0

6.9

0.89

0.90

mmol/l

0.01

796

5706

(3021901) Oxygen saturation in Capillary blood

235

1124

2.11

25.19

3.1

2.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

187

817

2.31

25.05

1.5

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

111

375

2.98

24.99

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

317

1693

1.90

24.91

6.8

3.7

8.48

8.71

kpa

1.41

310

1647

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

158

642

2.48

24.88

2.0

2.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

312

1659

1.91

24.84

7.1

5.0

406.63

1934.99

iu/ml

0.75

200

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

234

3.52

24.33

1.7

2.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

307

1637

1.90

24.25

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

165

706

2.36

23.22

1.9

2.3

73.42

73.79

0.12

158

684

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

337

1877

1.82

23.21

1.6

1.4

121.31

109.95

u/ml

0.38

386

(3043410) Blood group antigens tested for on Red Blood Cells

199

3.69

23.20

1.9

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1066

7788

1.41

22.84

1.3

1.2

147.50

145.13

iu/ml

0.06

358

3011

(42529406) Shigella sp [Presence] in Stool by Culture

445

2695

1.68

22.83

1.2

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

632

4167

1.55

22.83

2.3

2.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

433

2607

1.69

22.71

1.3

29.12

39.90

u/ml

0.53

181

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1255

9431

1.37

22.70

3.2

2.7

7.59

7.33

umol/l

0.16

1067

8083

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

343

1934

1.80

22.69

3.3

3.5

0.33

0.34

u/ml

0.29

184

1116

(4200892) Spirometry reversibility

807

5607

1.47

22.68

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

442

2680

1.68

22.58

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

382

2227

1.74

22.53

1.5

1.4

297.34

287.41

ug/g

0.43

219

1216

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

179

804

2.25

22.51

1.8

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

439

2663

1.68

22.39

1.2

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

394

2323

1.72

22.33

2.2

2.3

192.47

582.35

ug/l

3.60

365

2129

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

686

4627

1.51

22.30

1.9

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

236

1185

2.01

22.24

2.1

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2007

16186

1.29

22.21

1.3

51.06

27.95

iu/ml

0.73

620

5128

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

304

1664

1.85

22.16

2.0

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

265

1388

1.93

22.12

1.8

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

778

5394

1.48

22.10

3.2

2.1

5.31

7.25

ug/l

3.17

668

4753

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

435

2642

1.67

22.08

1.1

1.85

2.29

u/ml

0.42

203

1331

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

353

2026

1.77

22.00

1.3

1.4

3.86

3.64

mmol/l

2.85

341

1891

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

395

2341

1.71

21.97

1.3

21.20

5.45

u/ml

0.64

235

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

353

2027

1.77

21.96

1.5

1.4

13.23

23.81

u/ml

1.50

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1675

13206

1.32

21.91

2.9

2.8

2.44

2.43

mmol/l

0.17

1481

11482

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

235

1185

2.00

21.89

2.1

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1745

13843

1.31

21.82

1.9

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

207

998

2.09

21.79

1.5

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

327

1844

1.80

21.64

1.3

1.2

11.68

19.09

u/ml

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

288

1563

1.87

21.58

1.2

4.20

3.25

u/ml

0.22

543

(3014148) Varicella zoster virus Ab [Titer] in Serum

287

1556

1.87

21.57

1.2

—

(3016502) Oxygen saturation in Arterial blood

905

6491

1.43

21.47

8.5

7.4

94.97

96.04

3.55

870

6219

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

280

1509

1.88

21.45

1.2

3.49

4.09

u/ml

0.29

117

670

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

398

2381

1.70

21.39

1.4

1.3

11.44

9.76

u/ml

0.15

381

(3010503) CD19 cells [#/volume] in Blood

124

487

2.56

21.04

2.2

2.8

0.41

0.22

e9/l

0.28

116

479

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

295

1629

1.83

20.93

2.7

2.1

0.00

g/l

-0.00

275

1519

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

161

715

2.27

20.84

1.9

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

297

1651

1.82

20.62

2.7

2.1

0.01

0.00

g/l

0.32

275

1521

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

112

424

2.66

20.48

2.0

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

229

1173

1.97

20.44

2.1

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

319

1827

1.77

20.05

2.6

2.1

38.01

38.50

g/l

0.74

285

1629

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

248

4476

0.54

20.02

1.2

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

345

2031

1.72

19.69

1.6

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

299

1691

1.79

19.63

3.1

1.09

2.86

ratio

1.63

158

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

155

698

2.24

19.44

1.9

2.3

14.19

14.20

0.00

155

681

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

344

2032

1.72

19.40

1.3

1.5

10.34

23.88

e6/l

2.01

271

1571

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

344

2034

1.71

19.33

1.5

384.36

2722.25

e6/l

0.71

287

1653

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

122

498

2.47

19.13

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

304

1741

1.77

19.13

3.1

3.2

53.36

83.56

mg/l

0.44

283

1400

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

278

3.00

19.08

2.2

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

278

3.00

19.08

2.2

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

916

6719

1.40

19.06

3.7

3.9

18.45

25.85

ug/l

0.28

731

5188

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

378

2305

1.66

18.93

1.3

1.4

444.85

483.33

mg/l

0.97

370

2186

(3001019) Free T4 and TSH panel - Serum or Plasma

445

6827

0.64

18.93

1.6

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

532

3524

1.54

18.81

1.9

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

4.55

18.62

3.3

6.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

302

1741

1.76

18.59

3.1

3.2

40.17

48.89

mg/l

0.50

281

1401

(3016228) CD19 cells/100 cells in Blood

326

2.81

18.54

1.7

2.2

9.32

8.23

0.29

321

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

270

1509

1.81

18.46

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

927

6849

1.39

18.46

2.4

2.3

4813.36

6301.57

u/l

0.83

325

2729

(3026493) Urate [Moles/volume] in Serum or Plasma

2456

20689

1.24

18.37

3.0

2.3

11551.41

3304.81

umol/l

8.88

2220

18505

(3037121) Protein [Mass/volume] in Urine

424

2682

1.60

18.35

3.1

3.2

0.32

0.34

g/l

0.15

173

1197

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

308

1793

1.74

18.32

2.7

2.1

0.11

0.02

g/l

0.51

286

1657

(36304419) Bacteria [Presence] in Urine

2566

21753

1.23

18.04

3.8

2.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

458

2.48

18.02

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

536

3596

1.52

17.87

1.9

2.0

38.48

39.38

u/l

0.53

497

3262

(3002173) Hemoglobin [Mass/volume] in Arterial blood

828

6048

1.40

17.64

8.9

7.7

122.36

122.52

g/l

0.08

815

5860

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

6.32

17.52

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

360

2220

1.64

17.29

2.5

2.1

3.00

2.90

g/l

1.32

326

2023

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

115

480

2.41

17.23

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

200

1039

1.94

17.20

1.1

90.77

95.42

1.50

180

984

(3000012) Reticulocyte production index

169

827

2.06

17.20

1.8

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1861

15327

1.26

16.84

1.3

8.47

10.21

u/ml

0.68

859

6329

(21494814) CD8 cells/100 lymphocytes in Specimen

321

2.72

16.81

1.7

2.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2161

18119

1.24

16.64

4.6

4.4

2.70

2.91

ug/l

0.15

2014

16363

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

182

929

1.98

16.50

1.8

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

241

4150

0.57

16.47

1.7

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

281

1644

1.73

16.47

2.0

2.3

95.08

112.80

ug/min

0.24

129

1042

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1131

8765

1.32

16.43

1.6

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

135

617

2.20

16.41

1.3

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

367

2306

1.61

16.36

2.8

3.5

212.92

2502.40

u/ml

1.17

305

1971

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

139

644

2.17

16.33

3.4

2.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

228

1258

1.83

16.31

2.6

2.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

278

1626

1.73

16.31

2.1

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

327

1998

1.66

16.30

2.7

2.2

0.78

0.74

g/l

0.08

293

1748

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

214

1162

1.86

16.12

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

277

1626

1.72

16.05

3.7

2.9

25.28

24.44

mmol/l

2.88

269

1586

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

539

3722

1.47

15.61

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

524

3616

1.47

15.24

1.5

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2351

20050

1.22

15.19

3.7

3.3

—

(3023420) DNA double strand Ab [Units/volume] in Serum

195

1051

1.87

15.07

1.5

1.6

24.50

31.72

iu/ml

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2400

20536

1.22

14.97

2.6

2.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

187

997

1.89

14.95

1.7

1.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

371

2.49

14.91

1.1

1.08

13.84

u/ml

0.87

224

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

351

2233

1.59

14.89

5.9

4.1

1.35

1.36

mg/l

0.07

317

2091

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

162

824

1.98

14.88

1.9

1.5

—

(3024928) Oxygen saturation in Venous blood

248

1443

1.74

14.86

4.4

3.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

385

2506

1.56

14.79

1.3

1.2

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

161

824

1.97

14.54

1.9

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

141

3.49

14.51

3.8

2.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

559

3950

1.44

14.36

1.1

29.94

2.70

u/ml

0.55

(3003434) Protein [Mass/volume] in Pleural fluid

138

672

2.07

14.32

1.6

1.5

34.37

33.50

g/l

0.34

123

605

(3024891) Influenza virus A+B Ag [Presence] in Specimen

396

2616

1.53

14.24

1.2

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

125

591

2.13

14.02

1.9

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

125

591

2.13

14.02

1.9

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

125

591

2.13

14.02

1.9

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

305

1917

1.61

13.64

1.3

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

134

3.44

13.39

7.4

5.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

342

2.47

13.39

44.6

33.5

7.25

7.26

ug/l

0.01

314

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

131

643

2.05

13.34

2.4

2.8

707.63

750.89

e6/l

0.39

118

632

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

148

760

1.96

13.28

2.0

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

789

5982

1.34

13.27

1.4

—

(4062490) Immunoglobulin typing, IgG

176

960

1.85

13.16

1.4

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

138

696

2.00

13.05

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

809

6174

1.33

13.02

1.5

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

347

2273

1.54

13.00

2.0

10.93

10.57

mg/l

0.40

330

2138

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

190

1069

1.79

12.85

2.1

2.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

176

968

1.83

12.83

1.3

3.06

3.02

g/l

0.12

155

662

(3008116) Ketones [Moles/volume] in Urine by Test strip

158

3.17

12.82

1.2

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

310

1994

1.57

12.60

2.7

2.6

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

175

967

1.82

12.57

1.3

0.49

0.40

g/l

1.15

153

659

(3027135) IgG subclass 1 [Mass/volume] in Serum

175

967

1.82

12.57

1.3

6.58

6.71

g/l

0.22

153

661

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

437

3028

1.46

12.49

1.4

1.6

0.15

6.01

iu/ml

0.57

101

623

(3015377) Calcium [Moles/volume] in Serum or Plasma

2978

26348

1.18

12.42

3.4

3.2

2.35

mmol/l

1.01

2664

23542

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

221

1315

1.69

12.29

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

280

2.55

12.14

3.3

2.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

151

808

1.88

12.03

1.1

1.89

2.47

u/ml

0.22

278

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

175

2.98

12.01

1.2

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

246

1516

1.64

11.97

1.7

1.6

0.67

0.74

g/l

0.47

214

1147

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

313

2045

1.55

11.90

1.3

1.4

25.04

22.20

u/l

0.82

259

1697

(3008536) Aspergillus sp Ab [Presence] in Serum

135

3.27

11.85

2.4

2.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

339

2265

1.51

11.63

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

125

636

1.98

11.58

1.1

9.76

8.14

iu/ml

0.24

168

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1678

19723

0.82

11.58

1.4

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

154

840

1.85

11.57

1.4

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

330

2.37

11.50

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

4.51

11.39

5.2

3.7

2.17

2.46

mg/l

0.19

(3035947) Staphylolysin Ab [Units/volume] in Serum

350

2.32

11.39

1.0

1.1

5.50

3.91

iu/ml

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

128

661

1.95

11.37

2.4

2.7

499.60

523.27

e6/l

0.20

552

(3014599) Egg white IgE Ab [Units/volume] in Serum

147

795

1.86

11.36

1.1

1.62

5.25

u/ml

0.57

208

(3035880) pH of Pleural fluid

266

2.53

11.33

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.91

11.25

9.6

10.8

6.16

5.63

mmol/l

0.44

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

215

1302

1.66

11.23

3.8

3.6

26.90

28.68

u/ml

0.10

210

1256

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

236

1464

1.63

11.22

1.1

120.51

116.50

1.05

207

1332

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

182

1054

1.74

11.21

1.1

—

20.72

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

243

1526

1.61

11.00

2.3

2.0

132.34

131.73

g/l

0.13

166

1106

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2413

21206

1.18

10.65

1.8

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

361

2.25

10.63

1.9

1.7

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

153

856

1.80

10.63

1.1

281.74

236.86

mg/l

0.43

143

749

(3023410) Appearance of Cerebral spinal fluid

165

945

1.76

10.59

1.4

1.8

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

402

0.12

10.51

1.4

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

117

2170

0.53

10.50

2.9

2.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

156

883

1.78

10.43

1.1

47.37

39.20

mg/l

0.29

144

727

(3028707) Methadone [Presence] in Urine by Screen method

379

2651

1.44

10.37

2.9

2.8

—

(3042733) HLA Ab [Presence] in Serum

242

2.53

10.37

5.4

4.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

797

6265

1.29

10.35

2.8

3.4

4.43

4.56

pmol/l

3.85

704

5620

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

366

2.22

10.30

2.2

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

212

1317

1.62

10.07

2.6

3.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

101

502

2.02

10.06

1.5

1.3

6.58

6.25

mmol/l

0.52

465

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

365

2.20

9.95

2.3

1.8

—

(3023199) Leukocytes [#/volume] in Pleural fluid

116

608

1.92

9.93

1.6

1.5

5787.80

2397.85

e6/l

0.47

446

(3039443) Prostate specific Ag panel - Serum or Plasma

208

1298

1.61

9.71

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

137

766

1.80

9.59

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

511

3814

1.36

9.58

1.3

0.70

1.05

u/ml

0.41

332

(3028308) Erythrocytes [#/volume] in Pleural fluid

106

547

1.95

9.52

1.6

1.5

131022.06

64897.58

e6/l

0.45

327

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

129

713

1.82

9.39

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

665

5172

1.30

9.38

1.1

44.23

228.74

titre

4.71

143

(40768804) Tissue Pathology biopsy report

3900

35778

1.14

9.31

2.1

2.0

—

(1002224) Polysomnography panel

561

4267

1.33

9.28

1.1

—

(3009343) pH of Capillary blood

573

4373

1.33

9.26

6.6

3.5

7.41

0.18

487

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

428

3130

1.38

9.13

2.6

1.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

577

4419

1.32

9.10

6.6

3.5

5.19

5.11

kpa

1.29

544

4211

(3023183) Ammonium ion [Moles/volume] in Plasma

233

1520

1.54

9.03

3.0

31.47

35.17

umol/l

1.68

213

1403

(3001729) Color of Synovial fluid

4.07

8.96

1.2

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

311

2.23

8.89

2.2

2.5

230.00

234.09

e6/l

0.03

171

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.38

8.87

1.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

553

4229

1.32

8.82

6.6

3.5

1.92

1.39

mmol/l

2.74

420

3013

(3001964) Herpes simplex virus Ag [Presence] in Specimen

262

2.34

8.80

1.7

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

240

1586

1.52

8.78

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

214

2.48

8.75

1.8

1.3

—

(3023419) Bacteria identified in Sputum by Culture

149

878

1.71

8.73

3.4

2.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

198

1255

1.59

8.72

1.8

1.6

—

(3045788) Cell count panel - Pleural fluid

481

1.96

8.69

1.5

—

(40768446) Kidney Pathology biopsy report

308

2.22

8.67

2.0

1.6

—

(21494434) Karyotype in Bone marrow

101

533

1.90

8.54

1.2

—

(3000285) Sodium [Moles/volume] in Blood

3.67

8.42

1.3

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

117

653

1.80

8.30

2.6

2.7

0.21

0.22

e9/l

0.37

553

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

450

1.96

8.18

1.5

1.3

377.89

368.65

u/l

0.06

428

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

403

2.02

8.13

1.6

1.5

12.36

12.33

u/l

0.01

389

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

387

2843

1.37

8.08

2.3

1.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

217

2.40

8.03

4.7

6.2

24.97

24.79

mmol/l

0.12

203

(3003181) Sodium [Moles/volume] in Urine

171

1069

1.61

8.01

1.6

1.4

64.75

65.44

mmol/l

0.07

134

855

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

124

713

1.75

7.97

1.2

1.3

1.82

1.90

mmol/l

0.79

118

662

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.84

7.95

1.0

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

320

2284

1.41

7.93

3.5

3.8

1.41

1.37

mmol/l

0.26

300

2251

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.20

7.91

2.3

1.5

—

(3012441) Differential panel - Pleural fluid

527

1.87

7.86

1.7

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

137

814

1.69

7.84

1.3

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

140

840

1.68

7.73

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

179

2.52

7.71

2.1

1.7

50.05

46.31

u/l

0.03

164

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

372

2.02

7.62

1.1

1.2

—

(3037756) Immunofixation for Serum or Plasma

176

1122

1.58

7.62

1.8

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

286

2.17

7.61

2.3

1.9

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

123

716

1.73

7.60

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

123

716

1.73

7.60

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

124

724

1.72

7.58

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

124

724

1.72

7.58

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

124

724

1.72

7.58

1.2

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

776

9463

0.81

7.53

6.8

5.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

123

718

1.72

7.52

1.2

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

113

2.93

7.52

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

106

594

1.79

7.47

1.3

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

626

0.29

7.43

1.4

4.98

5.42

mmol/l

1.50

593

(3024471) HLA-A [Type]

257

2.22

7.41

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

109

2.94

7.36

1.8

2.5

1.08

1.46

mmol/l

0.44

(3019150) Specific gravity of Urine by Refractometry

1701

19280

0.86

7.26

3.8

3.5

1.02

kg/l

1.14

224

2861

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

111

639

1.74

7.16

1.5

38.88

32.43

0.97

390

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

274

2.16

7.15

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

282

2.13

7.06

2.3

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

282

2.13

7.06

2.3

1.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

230

1580

1.47

7.06

1.1

—

(3036180) Methadone [Presence] in Urine

113

657

1.73

7.04

2.4

2.7

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

212

2.32

7.03

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

212

2.32

7.03

1.3

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

159

1012

1.58

6.97

1.7

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

455

1.87

6.97

1.3

1.6

—

(3045414) Leukocytes [Presence] in Urine

275

3804

0.72

6.89

1.9

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

107

619

1.74

6.80

1.1

1.2

—

(40768806) Pleura Pathology biopsy report

553

1.78

6.79

1.7

1.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

410

1.91

6.77

2.3

2.5

9.46

9.90

0.17

388

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

158

1012

1.57

6.76

1.7

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

161

1037

1.56

6.72

1.7

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

158

1014

1.57

6.71

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

157

1007

1.57

6.68

1.7

1.4

—

(3011288) Drugs identified in Urine by Screen method

541

4293

1.27

6.60

3.4

2.9

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

212

2.27

6.59

1.3

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

158

1019

1.56

6.57

1.7

1.4

—

(3024932) HLA-DR beta [Type]

251

2.16

6.56

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

152

973

1.57

6.54

1.1

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

226

2.22

6.51

1.1

—

(3025130) Human papilloma virus identified in Specimen

247

1748

1.42

6.50

1.7

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

122

742

1.65

6.47

2.7

3.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

327

1.99

6.42

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

327

1.99

6.42

1.6

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.92

6.40

1.3

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.20

6.40

1.6

1.5

9.25

6.95

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

117

707

1.66

6.37

1.6

1.3

1.28

2.18

u/ml

0.63

383

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

223

2.20

6.29

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

318

2362

1.36

6.28

3.0

2.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

351

1.94

6.26

1.3

1.1

—

(3022670) pH of Venous cord blood

3.83

6.25

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

245

1747

1.41

6.20

1.3

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

3.66

6.18

1.2

1.6

1.09

0.70

0.17

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

367

1.91

6.16

1.5

1.8

161.97

151.24

0.55

342

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.96

6.15

2.9

1.4

40.88

45.84

umol/l

0.32

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.39

6.12

2.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

116

709

1.64

6.07

1.1

1.2

226.25

225.87

titre

0.00

138

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

176

2.33

6.04

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

153

1000

1.54

6.04

1.4

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

391

1.87

6.03

1.0

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

3.34

5.98

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

575

1.71

5.98

2.5

1.9

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

428

1.83

5.98

1.5

1.4

24.14

19.30

u/ml

0.33

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

448

3520

1.28

5.96

11.6

9.3

—

(3051651) Icteric interference index of Serum or Plasma

473

1.78

5.92

3.1

3.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

229

2.14

5.91

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

132

840

1.58

5.87

1.2

—

(3022313) Gas panel - Capillary blood

414

3227

1.29

5.86

7.3

3.7

—

(3017569) Oxygen content in Arterial blood

243

2.10

5.86

2.0

2.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

556

1.71

5.86

2.3

2.5

98.02

97.48

0.05

509

(36660697) Celiac disease serology panel - Serum

958

8177

1.19

5.82

1.1

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.78

5.80

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

196

1360

1.45

5.79

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

232

2.12

5.73

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

420

1.82

5.71

1.5

1.3

—

(3008898) HLA-B27 [Presence]

512

4111

1.26

5.71

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

414

1.82

5.66

1.5

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

151

2.39

5.60

1.5

1.18

3.01

1.72

130

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

208

2.17

5.60

1.4

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

521

6416

0.80

5.57

2.0

2.4

78.85

73.06

ml/min/173m2

1.36

252

2421

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.51

5.54

5.9

5.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.99

5.51

1.0

1.1

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.85

5.50

1.7

1.5

0.92

1.45

mg/l

0.36

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.85

5.50

1.7

1.5

1.85

1.90

mg/l

0.02

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.85

5.50

1.7

1.5

3.51

1.55

mg/l

0.77

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.85

5.50

1.7

1.5

4.58

3.98

mg/l

0.13

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.62

5.47

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

596

4898

1.23

5.40

2.3

2.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

392

1.82

5.38

2.2

2.4

27.51

27.62

0.03

375

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1920

21191

0.89

5.35

1.7

1.6

1.34

1.37

mmol/l

1.15

1828

18203

(3000492) Spirometry study

1081

9391

1.17

5.31

1.5

1.4

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

3.40

5.29

1.4

1.2

9.21

9.54

mg/l

0.06

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

149

2.35

5.29

3.2

4.3

41.71

73.65

u/l

1.24

144

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

139

2058

0.67

5.19

1.5

1.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

120

772

1.56

5.15

1.6

1.8

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.72

5.09

1.7

1.6

0.55

2.35

mg/l

2.74

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.75

5.08

4.8

3.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

152

2.31

5.08

1.6

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.84

5.07

1.0

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

2584

23812

1.11

5.06

3.0

3.2

13.27

7.95

mmol/l

0.51

2387

20612

(3017354) Segmented neutrophils/100 leukocytes in Blood

108

681

1.59

5.05

3.2

52.93

55.36

0.51

582

(3020650) Glucose [Presence] in Urine

277

0.25

4.96

1.3

1.4

—

(3004451) EKG impression Narrative

267

1.95

4.94

1.1

1.3

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

5.42

4.90

1.1

70.70

70.12

0.04

(3044941) Cell count panel - Synovial fluid

159

1100

1.45

4.85

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.99

4.81

3.1

3.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

377

1.78

4.81

27.6

23.8

127.17

120.99

ug/l

0.24

311

(40768797) Stomach Pathology biopsy report

1254

11097

1.15

4.80

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

168

1183

1.43

4.67

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

359

1.79

4.66

1.3

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

109

2.48

4.61

1.6

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

564

1.62

4.61

1.6

1.9

2.03

1.91

u/field

0.08

258

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.49

4.60

1.7

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

225

1671

1.35

4.57

1.6

13067.44

12080.88

e6/l

0.13

167

1220

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2114

19369

1.11

4.57

2.7

2.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

213

2.02

4.54

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

213

2.02

4.54

1.2

1.1

111.86

82.19

—

(3016879) Cocaine [Presence] in Urine

688

5835

1.19

4.54

2.3

2.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

3.15

4.47

1.0

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1318

11768

1.14

4.41

2.4

2.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.06

4.39

4.7

3.4

—

(3012516) Albumin [Mass/volume] in Urine

2176

20026

1.11

4.30

3.0

3.3

264.93

416.10

mg/l

1.13

1384

12908

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

236

1783

1.33

4.30

1.6

1.3

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

498

1.63

4.27

1.5

1.7

144.52

132.02

0.82

469

(3036670) Protein [Mass/volume] in Synovial fluid

171

2.11

4.27

1.1

1.2

36.07

38.66

g/l

0.44

(40767503) Oxygen content in Capillary blood by calculation

197

1450

1.37

4.27

2.9

2.1

16.55

16.84

0.45

140

667

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

370

1.73

4.24

1.2

1.3

51.67

56.06

titre

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

121

821

1.48

4.14

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

589

1.57

4.12

1.1

1.07

1.03

u/l

0.22

244

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

442

1.66

4.10

1.3

1.2

23.62

18.91

u/l

0.51

380

(3010726) Horse dander IgE Ab [Units/volume] in Serum

287

2248

1.28

4.04

1.1

1.70

2.02

u/ml

0.27

169

1145

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

216

1.95

4.04

1.1

92.50

68.54

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

189

2.01

4.01

1.6

1.4

70.07

63.23

0.75

157

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

149

1060

1.41

3.98

1.2

1.4

300.40

509.22

pmol/l

1.34

137

936

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

147

1046

1.41

3.93

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

819

9370

0.86

3.92

3.4

3.8

33.00

32.12

1.55

611

6758

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

103

685

1.51

3.90

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

111

752

1.48

3.85

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1910

17560

1.11

3.83

2.5

2.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

254

1974

1.29

3.82

4.0

3.92

3.87

mmol/l

0.93

240

1958

(3045142) Bone marrow Pathology biopsy report

105

705

1.49

3.81

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

490

1.60

3.81

1.9

2.8

46.11

43.57

0.45

272

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.53

3.79

1.1

1.7

205.25

27.09

ng/l

0.57

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1049

9325

1.14

3.78

2.3

1.9

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

354

1.70

3.74

1.3

1.1

104.17

111.36

0.77

316

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

317

1.74

3.73

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

325

4020

0.80

3.73

1.5

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

462

1.61

3.72

1.3

1.2

102.14

80.22

u/l

1.09

407

(3007566) Smooth muscle Ab [Titer] in Serum

319

2560

1.25

3.71

1.3

141.15

120.49

titre

0.15

245

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.50

3.70

1.1

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

6.67

3.67

1.1

—

(3011648) Oxygen content in Venous blood

575

1.53

3.65

4.3

3.3

10.61

11.21

0.64

575

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

809

7086

1.15

3.62

2.5

2.3

0.23

0.22

g/l

1.49

744

6618

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1169

10498

1.13

3.59

2.5

2.8

0.75

0.73

ug/l

0.15

710

6367

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

299

1.74

3.57

1.2

25.57

15.97

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

121

849

1.43

3.54

1.1

—

(1616796) Gas panel - Central venous blood

208

1592

1.31

3.54

4.4

3.2

—

(3028433) Virus identified in Specimen by Culture

293

1.74

3.52

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

5.30

3.50

1.1

—

(3011985) Renin [Units/volume] in Plasma

154

1130

1.37

3.48

1.5

1.6

43.80

67.52

mu/l

1.41

142

1023

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

494

1.56

3.48

1.8

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

108

746

1.45

3.44

4.1

3.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

357

2929

1.23

3.42

2.0

1.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

188

1.92

3.37

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

122

867

1.41

3.35

3.4

3.0

0.85

0.83

nmol/l

0.14

642

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

116

817

1.42

3.34

1.3

2.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

507

1.54

3.34

1.1

0.95

5.41

nmol/l

2.06

102

(3019832) Treponema pallidum Ab [Presence] in Serum

1776

16382

1.10

3.32

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

108

2.22

3.31

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

284

1.73

3.30

1.9

2.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

100

687

1.46

3.30

1.1

—

(3022621) pH of Urine by Test strip

625

5417

1.16

3.26

2.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

109

2.20

3.24

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

331

1.66

3.24

1.6

1.5

15.83

2.92

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

232

1826

1.28

3.23

1.5

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

129

2.10

3.22

1.4

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

264

1.75

3.21

1.1

73.88

55.41

u/ml

0.75

256

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

560

4818

1.17

3.21

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

306

2490

1.24

3.20

1.6

2.0

3.90

7.33

iu/l

0.56

1013

(3022689) Creatine [Moles/volume] in Urine

203

0.30

3.19

2.0

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

123

2.12

3.19

1.5

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.86

3.18

1.1

1.2

—

(3016038) Potassium [Moles/volume] in Urine

418

1.58

3.18

1.5

1.3

35.62

34.22

mmol/l

0.16

367

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

318

1.67

3.16

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

561

4839

1.17

3.12

1.4

—

(3006462) Nitrate [Presence] in Urine

417

0.45

3.11

4.2

2.8

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

148

1101

1.35

3.11

1.2

1.3

41.96

33.01

u/l

0.30

132

954

(4146454) Self-monitoring of blood glucose

677

0.57

3.07

2.6

2.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

665

1.45

3.06

1.9

2.1

23.36

25.22

ug/l

0.16

655

(3027008) Opiates [Presence] in Urine

722

6355

1.15

3.06

2.2

2.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

345

1.63

3.04

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

561

4852

1.16

3.03

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

246

3057

0.80

3.01

1.0

1.1

2.34

5.56

u/ml

2.91

455

(3000764) Benzodiazepines [Presence] in Urine

717

6317

1.14

3.00

2.2

2.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

668

1.44

3.00

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

582

5053

1.16

2.99

2.8

2.9

27.97

42.26

u/ml

3.30

561

4888

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

560

4849

1.16

2.98

1.4

—

(3017704) Immunofixation for Urine

301

1.66

2.97

1.4

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

271

1.70

2.96

3.0

3.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

340

1.62

2.95

1.1

93.19

91.28

0.14

152

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

162

1.92

2.93

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

116

839

1.39

2.92

1.6

57.65

54.61

0.34

530

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

4.71

2.91

1.4

1.2

—

(3028300) Cannabinoids [Presence] in Urine

721

6372

1.14

2.89

2.2

2.1

—

(3024263) Appearance of Synovial fluid

390

1.57

2.86

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

198

1554

1.28

2.86

1.2

1.4

7.49

6.86

mmol/l

1.03

1430

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

406

1.55

2.86

1.0

1.1

13.68

12.70

u/ml

0.12

244

(3004446) Plasmodium sp identified in Blood by Light microscopy

102

2.16

2.86

2.5

2.8

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

375

1.58

2.84

1.2

0.30

g/l

0.15

301

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

352

1.59

2.83

1.1

90.19

92.63

0.26

155

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

268

1.68

2.80

2.1

1.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.40

2.79

1.5

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

184

1436

1.29

2.79

1.5

1.9

5.35

5.23

mmol/24h

0.18

168

1281

(3019420) Tryptase [Mass/volume] in Serum or Plasma

546

1.47

2.79

1.4

1.5

5.67

7.06

ug/l

1.03

482

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

539

1.47

2.76

1.1

1334.31

1539.70

miu/ml

1.26

539

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

124

2.02

2.75

1.2

1.6

6.02

374264.48

nmol/l

1.08

101

(3010144) Erythrocytes [#/volume] in Synovial fluid

647

1.43

2.74

1.4

167099.99

89577.86

e6/l

0.50

453

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

347

1.59

2.74

1.3

18.04

11.91

u/l

0.96

323

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

159

1.89

2.74

1.0

1.1

20.73

19.64

mmol/l

0.90

144

(3044927) Protein electrophoresis panel - Urine

560

1.45

2.66

1.3

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

140

1062

1.32

2.64

1.1

1.3

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

127

1.97

2.59

1.0

3.03

3.32

kpa

0.41

109

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.30

2.57

1.1

—

3.50

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

153

1180

1.30

2.57

1.1

1.3

0.22

0.24

nmol/l

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

128

1.96

2.54

2.0

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

508

1.46

2.53

1.6

1.5

6.84

6.09

u/l

0.31

436

(3027231) Wheat IgE Ab [Units/volume] in Serum

246

1.67

2.51

1.0

1.1

1.08

2.01

u/ml

0.39

212

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

587

5173

1.14

2.50

3.1

2.6

192.32

165.70

ng/l

0.81

526

4615

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

140

1813

0.77

2.48

5.2

3.6

55.15

56.99

0.99

140

1813

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

4.38

2.47

1.1

1.0

1.71

2.31

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

3.13

2.43

1.1

0.21

0.22

g/l

—

(3029075) Extractable nuclear Ab panel - Serum

272

1.62

2.42

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.90

2.41

3.0

6.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

593

6688

0.88

2.40

1.4

1.3

22.01

25.41

iu/l

1.98

478

5763

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

590

1.41

2.38

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

297

1.58

2.37

3.2

2.4

—

(40768443) Skin Pathology biopsy report

417

3603

1.16

2.36

1.3

1.2

—

(3006598) pH of Arterial cord blood

132

1.90

2.35

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

132

1.90

2.35

1.0

7.25

7.53

kpa

0.31

115

(3004959) Base excess in Arterial cord blood by calculation

132

1.90

2.35

1.0

-1.66

-2.64

mmol/l

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

634

1.39

2.34

1.1

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.14

2.34

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.09

2.32

5.6

2.9

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

105

2.00

2.30

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

245

1.63

2.30

1.6

1.5

9.47

8.73

ug/l

0.38

245

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

216

0.42

2.29

1.2

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

698

6258

1.12

2.29

2.1

11.63

11.80

nmol/l

0.20

635

5663

(3006653) Thiamine [Moles/volume] in Blood

421

1.48

2.28

1.3

141.92

135.38

nmol/l

0.62

421

(3027944) Amphetamines [Presence] in Urine

698

6260

1.12

2.28

2.2

2.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.94

2.27

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

723

1.36

2.27

2.5

1.04

1.53

g/24h

1.38

378

(3021387) Prolactin [Units/volume] in Serum or Plasma

585

5193

1.13

2.26

1.5

1.6

316.28

311.32

mu/l

0.11

529

4666

(3020491) Glucose [Moles/volume] in Blood

681

1.37

2.26

1.8

1.9

5.71

6.16

mmol/l

0.77

519

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.89

2.25

1.0

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

415

1.47

2.23

2.8

2.4

104.21

180.29

umol/l

1.98

207

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

642

1.37

2.20

1.1

1.0

—

(3047189) Immunofixation for 24 hour Urine

257

1.60

2.17

3.0

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1268

11755

1.09

2.15

2.2

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

295

3470

0.85

2.15

1.4

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

198

0.40

2.15

1.3

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

159

1.76

2.12

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

2.00

2.10

1.1

—

(40763590) HLA-DQ beta [Type]

2.90

2.07

1.0

—

(40760410) HLA-B [Type] by High resolution

2.90

2.07

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.90

2.07

1.0

—

(40760409) HLA-A [Type] by High resolution

2.90

2.07

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

233

0.43

2.02

1.3

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

430

3776

1.14

2.00

1.3

1.4

11.38

9.32

u/l

1.97

347

3092

(3013862) HLA-DP [Type]

2.81

2.00

1.0

—

(3012565) Volume of 24 hour Urine

390

0.56

1.99

2.5

2.1

2215.45

2025.96

0.31

358

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

535

1.39

1.98

1.9

2.0

—

(3019060) Gas panel - Arterial blood

470

4156

1.14

1.97

4.1

4.7

—

(40758292) HTLV I+II Ab panel - Serum

156

1.73

1.95

1.7

1.3

—

(3018291) Platelet Ab [Presence] in Serum

4.55

1.94

1.8

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.19

1.94

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

187

1.66

1.93

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

360

0.55

1.92

1.3

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

180

1.67

1.91

1.2

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.24

1.90

1.2

1.1

5.38

14.78

u/l

1.24

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.92

1.89

1.2

1.53

1.74

mmol/l

0.35

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

121

1.82

1.87

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.39

1.85

1.5

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

741

1.31

1.84

1.8

1.4

—

(3049717) Cytology report of Urine Cyto stain

254

2159

1.18

1.83

2.2

2.5

—

(3019225) pH of Specimen

663

7298

0.90

1.82

5.2

3.8

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

4.17

1.82

1.0

1.2

—

(40768800) Prostate Pathology biopsy report

1005

0.74

1.80

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.57

1.80

3.3

3.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.57

1.80

1.2

1.4

—

(3047181) Lactate [Moles/volume] in Blood

186

2236

0.83

1.79

5.3

5.5

1.33

1.25

mmol/l

0.34

174

1954

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.96

1.79

1.0

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

271

1.51

1.78

2.0

1.8

188.14

15641.30

u/ml

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

116

1.81

1.78

1.2

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

404

1.41

1.75

1.2

1.3

164.54

157.05

mmol/24h

0.29

404

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

244

2079

1.18

1.73

1.7

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

155

1.68

1.72

1.5

1.6

0.24

0.41

ug/l

—

104

(3014891) Appearance of Pleural fluid

2.13

1.71

1.6

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

141

1.70

1.67

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.58

1.65

1.8

2.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.58

1.65

53.6

7.7

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.25

1.63

1.5

1.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

318

1.45

1.63

2.1

5.1

74.20

1279.02

mg/l

0.77

228

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

198

1.57

1.59

1.2

1.5

0.28

0.27

nmol/l

0.03

139

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.00

1.58

1.1

—

(3021788) Differential panel - Synovial fluid

156

1289

1.21

1.58

1.5

—

(40757494) Bilirubin.total [Moles/volume] in Blood

379

1.40

1.58

2.0

2.3

66.08

40.69

umol/l

—

(3008295) Osmolality of Serum or Plasma

762

1.28

1.55

1.5

282.50

281.02

mosm/kgh2o

0.29

601

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

3.33

1.52

1.2

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.59

1.51

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

101

1.78

1.48

1.2

1.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.00

1.48

1.0

1.1

25.93

24.26

u/l

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

243

2105

1.16

1.45

2.3

5.87

6.22

umol/l

0.17

180

1548

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.73

1.43

1.3

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.03

1.43

1.2

1.5

391.58

318.29

umol/24h

0.26

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

421

1.36

1.43

7.9

6.6

55.78

6939.11

u/ml

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

173

1.56

1.39

1.6

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

111

1.71

1.38

4.1

9.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.08

1.38

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.94

1.36

4.2

7.2

—

(3019977) pH of Arterial blood

323

1.39

1.35

3.3

2.8

7.42

0.19

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

120

1.67

1.33

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

128

1.64

1.32

1.5

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

1748

16690

1.06

1.32

3.1

2.4

5.92

6.63

e6/l

1.39

1548

14863

(3017732) Neutrophils [#/volume] in Blood

581

6320

0.91

1.32

2.3

2.5

4.75

4.71

e9/l

0.04

421

5360

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

367

1.36

1.32

1.2

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

300

1.40

1.30

1.5

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

136

1135

1.20

1.30

1.8

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

707

7620

0.92

1.30

3.5

3.0

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

2.35

1.29

1.3

1.1

0.04

0.03

mg/l

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.78

1.28

2.0

2.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

378

1.35

1.28

1.0

290.64

312.26

ng/l

0.28

270

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.29

1.26

1.5

5.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

172

1471

1.17

1.25

4.2

2.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

427

3876

1.11

1.25

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

777

1.24

1.25

1.5

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

149

1260

1.19

1.24

5.6

5.2

357.99

369.12

umol/l

0.43

128

1090

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

380

1.34

1.24

1.0

782.95

770.91

ng/l

0.07

265

(3046861) Legionella sp Ag [Presence] in Urine

2.40

1.24

1.5

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

227

1985

1.15

1.24

1.1

—

(3044889) 12 lead EKG panel

5834

57291

1.04

1.23

3.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

619

0.74

1.23

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

227

1987

1.15

1.22

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

468

1.31

1.22

2.2

1.6

1962333.33

1904688.63

iu/ml

—

(3013290) Carbon dioxide [Partial pressure] in Blood

140

1655

0.84

1.22

5.8

3.8

4.99

5.01

kpa

0.15

140

1622

(3040893) Potassium [Moles/volume] in Capillary blood

2.63

1.21

4.0

1.7

4.62

4.48

mmol/l

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

436

3969

1.10

1.21

1.5

—

(3012501) Base excess in Blood by calculation

140

1654

0.84

1.21

5.8

3.8

2.44

2.41

mmol/l

0.04

1071

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

382

1.34

1.21

1.0

34.75

42.32

ng/l

0.87

266

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

487

1.30

1.20

1.2

1.3

68.88

69.58

—

(3015183) Erythrocyte sedimentation rate

604

0.74

1.19

1.1

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

322

2888

1.12

1.19

8.8

3.8

24.75

24.55

mmol/l

0.61

300

2704

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.83

1.19

3.6

3.0

3.61

1.10

mg/l

—

(3005033) Fetal Nuchal fold Thickness US

425

3869

1.10

1.19

1.4

—

(3018418) pH of Serum or Plasma

2312

22301

1.05

1.18

5.1

3.7

7.39

7.40

1.33

278

4347

(40768793) Breast Pathology biopsy report

228

2003

1.14

1.18

1.2

1.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.77

1.16

1.0

1.2

4.66

1.72

mmol/l

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

174

1.50

1.14

1.3

1.2

830.15

289.38

pmol/l

0.45

124

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

1.75

1.12

1.0

21.03

15.11

u/ml

0.14

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

284

1.37

1.12

3.4

4.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.96

1.11

1.2

1.3

—

(40757373) Influenza virus identified in Isolate

143

1.54

1.11

2.2

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.73

1.08

2.5

3.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.73

1.08

1.0

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

143

1667

0.86

1.08

5.5

3.8

8.69

8.85

kpa

0.51

143

1633

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

364

1.32

1.07

1.4

1.2

—

(40768441) Liver Pathology biopsy report

603

1.25

1.07

1.6

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

666

1.23

1.07

1.1

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

703

1.23

1.06

1.6

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

161

1.49

1.06

1.1

0.79

0.73

umol/24h

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.92

1.06

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

2.12

1.05

1.6

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5729

58230

0.97

1.05

5.2

3.9

3337.27

1513.35

e6/l

0.86

669

(3034092) Cytoplasmic Ig cells/100 cells in Blood

125

0.48

1.04

6.7

6.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.96

1.03

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

211

1865

1.13

1.03

1.7

1.9

178.95

189.63

pmol/l

0.88

205

1778

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

535

1.25

1.03

1.2

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

608

1.24

1.01

1.2

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

708

1.22

1.00

1.6

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

870

9204

0.94

1.00

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

368

0.71

0.99

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

558

5193

1.08

0.99

1.4

1.5

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

387

1.29

0.99

2.0

2.1

9.09

9.60

mg/l

0.27

318

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

274

1.35

0.98

2.9

2.7

28.42

28.45

umol/l

0.01

194

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.80

0.98

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

756

1.21

0.98

1.0

1.1

300.96

288.18

mg/l

0.83

693

(3001186) Copper [Moles/volume] in Serum or Plasma

240

1.38

0.98

1.3

1.4

17.03

17.00

umol/l

0.02

210

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.97

0.0

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

215

1.40

0.97

1.2

1.3

113.14

117.49

nmol/l

0.07

162

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1503

14439

1.05

0.94

3.8

21.16

21.73

0.79

754

6241

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

106

898

1.18

0.93

1.0

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.22

0.93

1.0

—

(3034426) Prothrombin time (PT)

347

1.30

0.93

1.1

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

142

1.48

0.92

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

168

1.43

0.89

1.0

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

802

1.19

0.88

1.3

1.2

54.43

61.70

u/l

0.87

722

(3024869) Neuronal Ab [Presence] in Serum

119

1.51

0.87

1.2

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.86

0.87

1.1

19.53

17.71

g/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

383

4146

0.92

0.86

1.7

2.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

343

1.28

0.85

1.8

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.67

0.85

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

215

1932

1.12

0.84

1.0

1.1

3.50

4.83

u/ml

0.68

116

937

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.94

0.84

5.2

10.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

434

4035

1.08

0.83

6.7

23.98

24.39

mmol/l

1.46

407

3815

(3020191) Ethanol [Moles/volume] in Serum or Plasma

810

0.83

1.7

1.5

1.47

1.37

promille

0.21

617

(3029396) Erythrocyte agglutination [Presence] in Blood

478

0.77

0.82

3.1

3.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.88

0.81

2.2

2.6

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.79

0.0

1.3

—

20.99

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.67

0.78

1.3

1.5

20.86

23.22

nmol/l

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.78

0.0

1.4

—

1.90

—

(3034988) Calcium [Moles/volume] in Capillary blood

163

0.61

0.78

3.0

2.7

1.20

1.19

mmol/l

—

154

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

552

0.80

0.78

9.0

6.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.77

0.76

1.5

2.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

659

1.18

0.75

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.70

0.75

1.3

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

124

1.45

0.74

3.7

3.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.08

0.74

4.0

6.0

0.09

0.25

mmol/l

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

369

0.76

0.73

3.1

2.5

0.99

1.20

ug/l

0.40

343

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

167

1.38

0.73

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

847

1.16

0.73

1.6

1.4

—

(3014271) Vancomycin [Susceptibility]

263

1.29

0.72

3.4

2.8

—

(3044009) aPTT.lupus sensitive (LA screen)

100

1.50

0.72

1.1

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

501

0.80

0.71

1.2

1.3

—

(40765096) Chromosome analysis panel by Banding

203

1.33

0.70

1.0

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

663

0.83

0.69

2.5

2.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

144

0.62

0.69

1.4

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

168

0.65

0.67

41.1

6.8

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

594

1.18

0.67

1.8

1.4

87.11

76.91

umol/l

1.18

594

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.63

0.66

2.7

2.5

—

(3035933) Granulocytes/100 leukocytes in Blood

330

1.24

0.66

2.8

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

549

1.19

0.65

1.1

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

395

0.78

0.65

1.2

1.1

—

(3048879) Bone marrow aspiration report

154

1.36

0.64

1.8

2.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.47

0.64

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

189

0.69

0.63

1.5

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

189

0.69

0.63

1.5

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

189

0.69

0.63

1.5

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

189

0.69

0.63

1.5

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.67

0.61

1.4

2.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

479

0.81

0.61

1.0

—

(3042631) Mycobacterium sp identified in Specimen

805

1.14

0.61

2.6

2.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

135

1212

1.12

0.60

1.1

1.52

1.48

g/l

0.39

117

1108

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

140

0.64

0.60

2.8

2.4

1.18

1.20

mmol/l

—

133

(3045683) HLA typing for celiac disease panel - Blood or Tissue

716

0.85

0.60

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

254

0.75

0.58

2.5

11.3

—

(3017509) Phencyclidine [Presence] in Urine

166

1.33

0.58

2.4

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

123

1.38

0.57

1.1

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

759

7283

1.05

0.57

1.4

1.3

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

745

1.14

0.56

1.0

0.90

1.10

u/ml

0.15

191

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.67

0.56

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

347

1.21

0.56

1.8

1.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

330

0.79

0.55

5.4

6.1

—

(3025577) Chromium [Mass/volume] in Blood

330

0.79

0.55

1.8

2.0

2.91

2.30

ug/l

0.46

281

(40761995) Spermatozoa Progressive [#/volume] in Semen

330

0.79

0.55

2.7

3.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

171

1563

1.10

0.55

1.0

1.1

0.29

0.50

u/ml

0.58

417

(3052592) Norovirus Ag [Presence] in Stool

126

0.63

0.54

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

729

0.86

0.53

1.3

167.21

182.73

pmol/l

0.39

729

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.49

0.53

1.2

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

187

1.28

0.52

3.9

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

187

1.28

0.52

3.9

2.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

182

1975

0.92

0.52

1.3

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

468

4452

1.05

0.51

1.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

360

1.20

0.51

1.3

1.4

116.53

148.99

nmol/24h

0.28

360

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

112

1242

0.90

0.50

1.2

1.4

—

(3003157) Bacteria [#/volume] in Mother's milk

1.46

0.50

7.8

7.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

531

0.85

0.50

1.2

3.80

12.21

u/ml

—

(3019174) dRVVT (LA screen)

101

1.39

0.49

1.1

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

103

926

1.11

0.48

1.3

1.4

26.04

31.71

nmol/l

1.28

849

(4094501) Cardiovascular stress test using bicycle ergometer

220

2049

1.08

0.48

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.45

0.48

1.3

1.4

—

(3002256) Pathology report gross observation

1068

10998

0.97

0.46

1.3

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

1.46

0.46

1.1

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

155

1.29

0.46

1.2

1.4

13.08

12.64

g/l

0.06

116

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

200

1.25

0.46

1.9

2.6

—

(3008607) Semen analysis panel

0.60

0.45

1.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

119

0.67

0.45

1.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

665

1.13

0.45

1.2

1.08

1.05

ratio

0.70

238

(3038071) Oxygen [Partial pressure] in Mixed venous blood

153

0.72

0.45

41.1

7.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1090

10595

1.03

0.45

1.6

—

(3022145) Colonoscopy Study observation

901

9293

0.97

0.44

1.3

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

544

1.14

0.44

1.7

1.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

471

1.15

0.42

2.9

3.3

7.55

8.08

mg/l

0.29

366

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.40

0.42

1.9

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

444

1.15

0.41

1.8

1.7

104.92

4.27

nmol/l

0.47

360

(40758358) Immune stain study

1.52

0.41

1.0

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.41

0.0

1.0

—

0.01

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.41

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3456

34120

1.02

0.40

8.0

5.4

1.21

mmol/l

4.35

3258

31278

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.47

0.40

1.0

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

1.33

0.40

3.0

2.1

255.13

467.16

umol/l

—

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.12

—

(3028717) Thiamine [Mass/volume] in Blood

101

0.69

0.39

1.0

1.2

—

(3013762) Body weight Measured

1.35

0.37

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

257

0.82

0.37

2.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

879

1.09

0.35

2.5

2.1

20.71

19.71

nmol/l

0.43

837

(3027923) C peptide [Moles/volume] in Serum or Plasma

417

0.86

0.35

2.3

1.9

1.68

1.32

nmol/l

0.79

330

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

319

1.16

0.35

1.6

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

233

0.82

0.34

2.8

2.5

50.67

103.73

ng/l

1.52

128

(4281824) Cell count and differential, peritoneal fluid

876

0.91

0.33

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.30

0.31

2.3

2.8

15.42

7.69

—

(40768795) Lymph node Pathology biopsy report

769

0.91

0.31

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.35

0.31

1.0

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

190

1799

1.06

0.31

1.0

1.1

5.31

5.62

u/ml

0.09

771

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.32

0.30

1.0

159.14

165.26

g/l

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

463

0.89

0.30

1.1

1.2

208.14

305.50

u/l

0.86

427

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

245

2338

1.05

0.30

1.3

3.42

3.69

ug/l

0.43

223

2145

(4212803) Bone marrow aspirate examination

1.27

0.30

1.0

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

141

1325

1.06

0.29

2.7

3.4

433.01

498.11

u/ml

0.07

127

1214

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.23

0.29

7.6

4.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

139

1.22

0.29

1.7

—

(3033799) Differential panel - Peritoneal fluid

195

0.82

0.28

2.5

2.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

246

2355

1.05

0.27

1.4

112.71

111.90

pmol/l

0.01

241

2297

(3022475) Manganese [Moles/volume] in Blood

1.25

0.27

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

787

1.08

0.27

3.8

13.7

7.58

7.10

mmol/l

0.45

639

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

807

1.08

0.27

1.3

1.2

5.55

5.79

umol/l

0.21

747

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

225

1.16

0.26

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

329

1.13

0.25

2.1

61.08

188.43

ug/min

0.86

(3036048) Francisella tularensis Ab [Titer] in Serum

216

1.16

0.25

1.2

1.1

—

180.00

—

(3001556) Androgen free Index in Serum or Plasma

181

0.83

0.25

1.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

159

0.82

0.24

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

216

2070

1.04

0.24

1.3

1.4

—

(3045424) Erythrocytes [Presence] in Urine

130

1373

0.95

0.24

1.3

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.77

0.22

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

932

1.06

0.22

4.7

4.5

192.61

68.40

u/ml

0.73

297

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

172

1.16

0.22

1.1

1.3

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.21

0.0

1.1

—

(4035726) Immunohistochemistry procedure

670

6563

1.02

0.21

1.4

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1475.83

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

402

1.09

0.20

1.5

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

644

1.07

0.20

1.4

1.2

45.29

76.53

u/ml

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.20

0.0

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

648

1.07

0.18

1.4

1.2

7.00

47.86

u/ml

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

129

1.16

0.17

2.1

2.9

25.87

35.54

mg/l

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.13

0.16

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

632

1.06

0.16

1.2

1.3

1.53

1.56

g/l

0.39

632

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

506

1.07

0.15

1.0

1.1

11.39

10.52

u/ml

0.07

104

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

149

1.14

0.15

1.0

0.03

0.09

u/ml

0.75

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.77

0.15

1.0

—

(3044007) Cell count panel - Peritoneal fluid

182

0.88

0.15

1.8

1.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.13

0.15

1.9

2.2

0.89

0.71

u/field

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

348

0.92

0.15

1.8

1.5

14.40

14.48

pmol/l

0.04

296

(3024666) Lithium [Moles/volume] in Serum or Plasma

732

1.05

0.14

12.1

11.5

0.58

0.60

mmol/l

0.47

672

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

431

1.07

0.13

1.5

1.6

1.49

3.21

u/field

2.07

311

(3004616) Nuclear Ab [Presence] in Serum

112

1078

1.04

0.13

1.6

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

315

1.08

0.13

1.6

1.7

53.20

188.81

au/ml

—

(3010421) pH of Blood

188

1932

0.97

0.13

4.9

3.7

7.42

0.15

147

1763

(40762365) Oxygen content in Arterial blood by calculation

109

0.83

0.13

1.8

2.7

14.99

14.67

ml/dl

—

101

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

200

1.10

0.12

1.5

1.9

5820.62

16444.99

e6/l

0.50

111

(3042517) Benzodiazepines panel - Urine

168

0.89

0.11

5.0

2.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1359

13481

1.01

0.11

1.7

1.48

1.39

2.46

1256

12084

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

621

1.05

0.11

1.4

1.2

2.11

14.54

u/ml

—

(3032057) Clostridioides difficile [Presence] in Stool

157

0.89

0.11

2.5

2.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

227

2225

1.02

0.10

1.5

0.53

0.44

nmol/l

0.37

192

1789

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

493

0.95

0.09

1.0

96.17

93.09

0.30

396

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.04

0.09

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

122

1253

0.97

0.09

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

399

1.05

0.09

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

155

0.90

0.09

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.13

0.09

1.2

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.79

0.08

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

170

1666

1.02

0.08

1.0

1.1

4.24

3.08

u/ml

0.39

868

(3007463) Buprenorphine [Presence] in Urine

1.08

0.08

3.4

5.3

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

137

1.09

0.07

1.0

0.02

0.21

u/ml

0.80

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

108

1.11

0.07

1.0

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

112

0.89

0.07

1.9

1.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

266

1.05

0.06

1.1

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.11

0.05

1.0

—

(40761535) Cells panel - Urine sediment

635

6308

1.01

0.05

3.8

3.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

189

1.06

0.04

1.5

1.8

4.08

3.75

ug/l

0.05

104

(3002619) Bacteria identified in Specimen by Culture

190

1.05

0.04

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

200

0.95

0.03

1.3

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

876

1.02

0.03

2.0

25.38

23.54

mg/l

0.11

237

(43055514) Macroprolactin [Presence] in Serum or Plasma

389

1.03

0.03

1.1

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

176

1744

1.01

0.03

2.0

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

416

4177

1.00

0.02

1.8

1.6

4.19

3.79

mg/l

0.39

308

2954

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

136

0.96

0.00

1.1

1.2

586.90

322.17

ug/l

—

(3030313) Adrenal Ab [Titer] in Serum

115

1.04

0.00

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

497

1.01

0.00

1.9

1.6

5.76

6.54

u/l

0.15

412

(3023487) Leukocytes [#/volume] in Peritoneal fluid

226

1.02

0.00

1.8

2.1

568.00

4210.29

e6/l

0.56

162

(3016330) Potassium [Moles/time] in 24 hour Urine

128

1.02

0.00

1.2

—

96.20

—

(3020891) Body temperature

271

2705

1.00

0.00

5.2

4.3

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

58.53

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

21.00

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

10.60

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.99

-0.00

1.0

0.56

0.20

u/ml

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

1.7

—

10.71

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

22.63

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

8.6

—

15.20

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.95

-0.00

1.1

1.89

1.74

umol/24h

—

Mortality – FinRegistry

↥

Association

Association between endpoint U22_COVID19_SUSPECTED and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have U22_COVID19_SUSPECTED.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: U22_COVID19_SUSPECTED – Covid-19 suspected case

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Covid-19 suspected case

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints